Effect of P2X purinergic receptors in tumor progression and as a potential target for anti-tumor therapy

The development of tumors is a complex pathological process involving multiple factors, multiple steps, and multiple genes. Their prevention and treatment have always been a difficult problem at present. A large number of studies have proved that the tumor microenvironment plays an important role in...

Full description

Saved in:
Bibliographic Details
Published inPurinergic signalling Vol. 17; no. 1; pp. 151 - 162
Main Author Zhang, Wen-jun
Format Journal Article
LanguageEnglish
Published Dordrecht Springer Netherlands 01.03.2021
Springer Nature B.V
Subjects
Apoptosis
Biomedical and Life Sciences
Biomedicine
Cancer Research
Cancer therapies
Cell proliferation
Fluidity
Human Physiology
Membrane fluidity
Neurosciences
Pharmacology/Toxicology
Purine P2X receptors
Purine receptors
Review
Review Article
Tumor cells
Tumor microenvironment
Tumors
P2X purinergic receptors
Tumor microenvironment
ATP
Tumors
Online AccessGet full text

Cover

Abstract The development of tumors is a complex pathological process involving multiple factors, multiple steps, and multiple genes. Their prevention and treatment have always been a difficult problem at present. A large number of studies have proved that the tumor microenvironment plays an important role in the progression of tumors. The tumor microenvironment is the place where tumor cells depend for survival, and it plays an important role in regulating the growth, proliferation, apoptosis, migration, and invasion of tumor cells. P2X purinergic receptors, which depend on the ATP ion channel, can be activated by ATP in the tumor microenvironment, and by mediating tumor cells and related cells (such as immune cells) in the tumor microenvironment. They play an important regulatory role on the effects of the skeleton, membrane fluidity, and intracellular molecular metabolism of tumor cells. Therefore, here, we outlined the biological characteristics of P2X purinergic receptors, described the effect of tumor microenvironment on tumor progression, and discussed the effect of ATP on tumor. Moreover, we explored the role of P2X purinergic receptors in the development of tumors and anti-tumor therapy. These data indicate that P2X purinergic receptors may be used as another potential pharmacological target for tumor prevention and treatment.
AbstractList The development of tumors is a complex pathological process involving multiple factors, multiple steps, and multiple genes. Their prevention and treatment have always been a difficult problem at present. A large number of studies have proved that the tumor microenvironment plays an important role in the progression of tumors. The tumor microenvironment is the place where tumor cells depend for survival, and it plays an important role in regulating the growth, proliferation, apoptosis, migration, and invasion of tumor cells. P2X purinergic receptors, which depend on the ATP ion channel, can be activated by ATP in the tumor microenvironment, and by mediating tumor cells and related cells (such as immune cells) in the tumor microenvironment. They play an important regulatory role on the effects of the skeleton, membrane fluidity, and intracellular molecular metabolism of tumor cells. Therefore, here, we outlined the biological characteristics of P2X purinergic receptors, described the effect of tumor microenvironment on tumor progression, and discussed the effect of ATP on tumor. Moreover, we explored the role of P2X purinergic receptors in the development of tumors and anti-tumor therapy. These data indicate that P2X purinergic receptors may be used as another potential pharmacological target for tumor prevention and treatment.
The development of tumors is a complex pathological process involving multiple factors, multiple steps, and multiple genes. Their prevention and treatment have always been a difficult problem at present. A large number of studies have proved that the tumor microenvironment plays an important role in the progression of tumors. The tumor microenvironment is the place where tumor cells depend for survival, and it plays an important role in regulating the growth, proliferation, apoptosis, migration, and invasion of tumor cells. P2X purinergic receptors, which depend on the ATP ion channel, can be activated by ATP in the tumor microenvironment, and by mediating tumor cells and related cells (such as immune cells) in the tumor microenvironment. They play an important regulatory role on the effects of the skeleton, membrane fluidity, and intracellular molecular metabolism of tumor cells. Therefore, here, we outlined the biological characteristics of P2X purinergic receptors, described the effect of tumor microenvironment on tumor progression, and discussed the effect of ATP on tumor. Moreover, we explored the role of P2X purinergic receptors in the development of tumors and anti-tumor therapy. These data indicate that P2X purinergic receptors may be used as another potential pharmacological target for tumor prevention and treatment.The development of tumors is a complex pathological process involving multiple factors, multiple steps, and multiple genes. Their prevention and treatment have always been a difficult problem at present. A large number of studies have proved that the tumor microenvironment plays an important role in the progression of tumors. The tumor microenvironment is the place where tumor cells depend for survival, and it plays an important role in regulating the growth, proliferation, apoptosis, migration, and invasion of tumor cells. P2X purinergic receptors, which depend on the ATP ion channel, can be activated by ATP in the tumor microenvironment, and by mediating tumor cells and related cells (such as immune cells) in the tumor microenvironment. They play an important regulatory role on the effects of the skeleton, membrane fluidity, and intracellular molecular metabolism of tumor cells. Therefore, here, we outlined the biological characteristics of P2X purinergic receptors, described the effect of tumor microenvironment on tumor progression, and discussed the effect of ATP on tumor. Moreover, we explored the role of P2X purinergic receptors in the development of tumors and anti-tumor therapy. These data indicate that P2X purinergic receptors may be used as another potential pharmacological target for tumor prevention and treatment.
Author Zhang, Wen-jun
Author_xml – sequence: 1
  givenname: Wen-jun
  orcidid: 0000-0001-6056-2054
  surname: Zhang
  fullname: Zhang, Wen-jun
  email: 707384731@qq.com
  organization: Gastrointestinal Surgery, The Second Affiliated Hospital, Nanchang University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33420658$$D View this record in MEDLINE/PubMed
BookMark eNp9kUtv1TAQhS1URB_wB1ggS2zYpDh-xM4GCVXlIVWCBUjsLMcZ57rKtYPtIPXf45JyoV10ZWv8nZkzPqfoKMQACL1syXlLiHyb25YR2hBKGtLLrm3UE3TSCsmaXvDu6HBn6hid5nxNiOCU9c_QMWOckk6oE7S7dA5swdHhr_QHXtbkA6TJW5zAwlJiytgHXNZ9THhJcUqQs48BmzBik7HBSywQijczLiZNULCrpKmVZhOVHSSz3DxHT52ZM7y4O8_Q9w-X3y4-NVdfPn6-eH_VWC55aYywAx2AgmIwSNEzN3bKOOmIYi3vqWTDUOtMjdRwOTrrDOWiBxCkp3RU7Ay92_ou67CH0VZvycx6SX5v0o2Oxuv7L8Hv9BR_aVk_rZd9bfDmrkGKP1fIRe99tjDPJkBcs6ZcdqJrO8kr-voBeh3XFOp6mgoqOiU6ySr16n9HByt_Q6gA3QCbYs4J3AFpib5NWm9J65q0_pO0vhWpByLriyk1mrqVnx-Xsk2a65wwQfpn-xHVbzNhvpg
CitedBy_id crossref_primary_10_1016_j_kint_2024_10_024
crossref_primary_10_15407_ubj96_03_005
crossref_primary_10_1016_j_cellimm_2024_104901
crossref_primary_10_1007_s00438_025_02227_9
crossref_primary_10_1016_j_prp_2025_155844
crossref_primary_10_1002_imed_1052
crossref_primary_10_1039_D3BM00463E
crossref_primary_10_1016_j_biopha_2022_114205
crossref_primary_10_1016_j_humimm_2024_111105
crossref_primary_10_1016_j_bbrc_2021_04_076
crossref_primary_10_3389_fonc_2023_1297775
crossref_primary_10_1007_s11302_024_09989_8
crossref_primary_10_3389_fphar_2024_1483716
crossref_primary_10_1007_s11302_021_09839_x
crossref_primary_10_1007_s11302_023_09983_6
crossref_primary_10_1007_s11302_024_10000_7
crossref_primary_10_1016_j_abb_2024_110194
crossref_primary_10_1016_j_brainresbull_2022_09_009
crossref_primary_10_3389_fcell_2023_1147242
crossref_primary_10_18632_aging_205364
crossref_primary_10_1007_s11302_024_10053_8
crossref_primary_10_1016_j_ejmech_2023_115877
Cites_doi 10.1007/s12035-010-8120-x
10.1186/s12943-015-0469-z
10.1016/j.cytogfr.2016.11.004
10.1016/j.neuropharm.2015.02.014
10.1158/0008-5472.CAN-11-1947
10.1111/j.0309-0167.2004.01798.x
10.1111/j.1744-313X.2011.01019.x
10.1016/j.jneuroim.2004.04.005
10.1038/s41568-018-0037-0
10.1085/jgp.200810059
10.1172/jci.insight.130000
10.1016/j.lungcan.2015.10.005
10.1016/j.humpath.2017.03.019
10.1038/s41388-019-0684-y
10.1016/j.cmet.2017.06.016
10.1016/j.immuni.2019.01.020
10.1080/09553002.2016.1206222
10.1002/jnr.22538
10.1021/acs.jmedchem.5b01690
10.2174/0929867322666141210155311
10.1016/S0022-5347(05)67618-5
10.2174/0929867321666141215093513
10.1097/MPA.0000000000001055
10.1371/journal.pone.0019983
10.1016/j.ejmech.2013.10.026
10.1007/s10555-019-09796-3
10.1007/s12020-010-9384-7
10.3892/or.2016.4827
10.1016/j.canlet.2007.10.025
10.1038/onc.2014.444
10.1111/imr.12738
10.1038/ncomms4364
10.1186/s12974-017-0904-8
10.7150/thno.14843
10.1038/srep16222
10.1158/0008-5472.CAN-14-1259
10.1097/MOO.0000000000000031
10.1007/s11427-017-9178-y
10.1007/5584_2017_55
10.1007/s00424-006-0070-9
10.3892/or.2015.3979
10.1016/j.pharep.2019.08.002
10.1002/path.4907
10.2174/1389450117666160711154529
10.1016/j.ejcb.2012.04.004
10.1038/cddis.2014.109
10.1038/nrc.2016.73
10.3389/fimmu.2018.01722
10.1093/abbs/gmp016
10.1113/JP273309
10.1371/journal.pone.0060184
10.3233/CBM-170258
10.1172/JCI81135
10.1016/j.jaut.2019.102310
10.2174/0929867321666141011195351
10.1038/cr.2016.151
10.1038/nrclinonc.2016.217
10.1073/pnas.93.8.3684
10.1007/s11302-014-9411-x
10.2174/0929867321666141215094050
10.1016/bs.acc.2015.12.005
10.1039/C5TB02764K
10.1016/j.biopha.2020.109844
10.1007/978-3-319-55231-6_16
10.1038/nrc3380
10.1016/j.it.2016.01.004
10.1007/s00018-017-2686-7
10.1016/j.semcdb.2015.02.009
10.4161/cc.8.22.10026
10.1038/s41575-019-0115-0
10.1016/j.biocel.2013.02.009
10.2174/0929867321666141215094749
10.1007/s11302-019-09675-0
10.1016/j.ccell.2019.10.007
10.1038/s41586-019-1170-y
10.1517/14728220903277249
10.1007/978-1-4899-8032-8_2
10.7554/eLife.38358
10.18632/oncotarget.4926
10.1038/srep26280
10.1186/1477-5751-13-16
10.1111/j.1464-410X.2007.07293.x
10.1007/978-1-4939-7435-1_2
10.1016/j.bbrc.2014.03.048
10.1002/jcp.27411
10.1007/s11302-017-9593-0
10.1016/j.brainresbull.2019.11.006
10.1007/s11033-018-4432-0
10.1007/s11302-015-9493-0
10.1093/carcin/bgu019
10.1186/s40425-019-0773-z
10.1016/j.coph.2019.03.001
10.3389/fphar.2017.00291
10.1016/j.neuroscience.2015.02.011
10.1016/bs.mie.2019.10.006
10.1593/neo.101332
10.3389/fphar.2019.00612
10.1038/onc.2010.593
10.1016/j.oraloncology.2018.03.004
10.1016/j.advms.2019.05.002
10.1158/0008-5472.CAN-18-3962
10.1007/978-3-319-78127-3_6
10.21873/anticanres.11345
10.1515/hsz-2018-0121
10.3390/ijms20184413
10.1038/nature11010
10.1002/jcp.28657
10.1016/j.bbrc.2014.07.101
10.1007/s00018-014-1600-9
10.1016/j.bpc.2017.02.005
10.1146/annurev-physiol-020518-114259
10.1152/jn.01171.2002
10.1085/jgp.201611595
10.2174/0929867321666140706130415
10.3233/CBM-181368
10.3390/molecules24193575
10.1098/rstb.2015.0427
10.1038/s41586-018-0235-7
10.1186/s12906-019-2615-4
10.1016/j.canlet.2014.06.008
10.3390/cancers12092342
10.1016/j.cell.2018.01.009
10.1016/j.bcp.2009.06.016
10.1186/s13045-019-0772-z
10.1073/pnas.0935978100
10.1016/j.molonc.2015.09.006
10.1016/j.bbamcr.2019.118523
10.1007/s11033-018-4309-2
10.1016/j.phrs.2017.05.004
10.1021/acsami.7b10840
10.1111/j.1742-4658.2009.07228.x
10.1002/ijc.32207
10.1016/j.phrs.2020.104875
10.1038/s41419-019-2042-y
10.1016/S0140-6736(02)11917-9
10.2174/0929867321666141012172913
10.1002/glia.20397
10.1016/j.leukres.2017.07.004
10.1152/ajpgi.00211.2004
10.1631/jzus.B1500266
10.1158/0008-5472.CAN-09-3566
10.1007/164_2019_312
10.1158/0008-5472.CAN-17-2549
10.1186/1471-2407-9-114
10.1158/1078-0432.CCR-18-0125
10.1097/PPO.0000000000000312
10.3892/ol.2014.2620
10.1038/ni.2703
10.1038/s41573-019-0052-1
10.1186/s12967-019-2101-2
10.1007/s11095-018-2449-7
10.18632/oncotarget.16903
10.1371/journal.pone.0080707
10.1016/j.lfs.2019.116952
10.1158/0008-5472.CAN-14-1778
10.3390/medicina56010015
10.1038/s41416-018-0333-1
10.1073/pnas.1222251110
10.18632/oncotarget.18595
10.1016/j.canlet.2014.04.001
10.2174/1871527315666160922104848
10.1155/2016/6058147
10.1038/srep32602
10.1371/journal.pone.0114371
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer Nature B.V. part of Springer Nature 2021
The Author(s), under exclusive licence to Springer Nature B.V. part of Springer Nature 2021.
Copyright_xml – notice: The Author(s), under exclusive licence to Springer Nature B.V. part of Springer Nature 2021
– notice: The Author(s), under exclusive licence to Springer Nature B.V. part of Springer Nature 2021.
DBID AAYXX
CITATION
NPM
7X8
5PM
DOI 10.1007/s11302-020-09761-8
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1573-9546
EndPage 162
ExternalDocumentID PMC7954979
33420658
10_1007_s11302_020_09761_8
Genre Journal Article
Review
GrantInformation_xml – fundername: Natural Science Foundation of Jiangxi Province
  grantid: 20202BABL206163 and 20202BABL206091
  funderid: http://dx.doi.org/10.13039/501100004479
– fundername: Natural Science Foundation of Jiangxi Province
  grantid: 20202BABL206163 and 20202BABL206091
– fundername: ;
  grantid: 20202BABL206163 and 20202BABL206091
GroupedDBID ---
-56
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
123
1N0
203
29P
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2WC
2~H
30V
4.4
406
408
409
40D
40E
53G
5VS
67N
67Z
6NX
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABWNU
ABXPI
ACAOD
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSNA
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFGCZ
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
AOIJS
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BAWUL
BDATZ
BGNMA
BSONS
CAG
COF
CS3
CSCUP
DDRTE
DIK
DNIVK
DPUIP
DU5
E3Z
EBLON
EBS
EIOEI
EJD
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GX1
GXS
H13
HF~
HG5
HG6
HLICF
HMJXF
HQYDN
HRMNR
HVGLF
HYE
HZ~
I09
IHE
IJ-
IKXTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KPH
LAK
LLZTM
M4Y
MA-
N2Q
NB0
NPVJJ
NQJWS
NU0
O9-
O93
O9I
O9J
OAM
OK1
P2P
PF0
PT4
QOR
QOS
R89
R9I
RIG
ROL
RPM
RPX
RSV
S16
S1Z
S27
S3A
S3B
SAP
SBL
SDH
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZN
T13
TR2
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
Z7U
ZMTXR
ZOVNA
~A9
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
NPM
ABRTQ
7X8
5PM
ID FETCH-LOGICAL-c474t-a5cb2be2e83eb7593fd68af7f083149273bbb7538d2a47dfcfa2459ee50922d83
IEDL.DBID U2A
ISSN 1573-9538
1573-9546
IngestDate Thu Aug 21 18:04:15 EDT 2025
Fri Jul 11 15:42:46 EDT 2025
Fri Jul 25 11:09:05 EDT 2025
Thu Apr 03 06:59:13 EDT 2025
Tue Jul 01 00:34:44 EDT 2025
Thu Apr 24 23:07:57 EDT 2025
Fri Feb 21 02:48:28 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords P2X purinergic receptors
Tumor microenvironment
ATP
Tumors
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c474t-a5cb2be2e83eb7593fd68af7f083149273bbb7538d2a47dfcfa2459ee50922d83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0001-6056-2054
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/7954979
PMID 33420658
PQID 2525685673
PQPubID 2043646
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7954979
proquest_miscellaneous_2476561674
proquest_journals_2525685673
pubmed_primary_33420658
crossref_primary_10_1007_s11302_020_09761_8
crossref_citationtrail_10_1007_s11302_020_09761_8
springer_journals_10_1007_s11302_020_09761_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-03-01
PublicationDateYYYYMMDD 2021-03-01
PublicationDate_xml – month: 03
  year: 2021
  text: 2021-03-01
  day: 01
PublicationDecade 2020
PublicationPlace Dordrecht
PublicationPlace_xml – name: Dordrecht
– name: Netherlands
PublicationSubtitle The Official Journal of the International Purine Club
PublicationTitle Purinergic signalling
PublicationTitleAbbrev Purinergic Signalling
PublicationTitleAlternate Purinergic Signal
PublicationYear 2021
Publisher Springer Netherlands
Springer Nature B.V
Publisher_xml – name: Springer Netherlands
– name: Springer Nature B.V
References Huang, Lin, Taniguchi (CR58) 2017; 60
Shimasaki, Jain, Campana (CR95) 2020; 19
Solini, Simeon, Derosa, Orlandi, Rossi, Fontana, Galli, di Desidero, Fioravanti, Lucchesi, Coltelli, Ginocchi, Allegrini, Danesi, Falcone, Bocci (CR140) 2015; 6
Zhang, Hu, Zhu (CR5) 2020; 125
Tong, Tong, Liu (CR64) 2018; 53
Khan, Spicer (CR149) 2019; 260
Albuquerque, Balmaña, Mereiter, Pinto, Reis, Beltrão (CR66) 2018; 399
Stokes, Layhadi, Bibic, Dhuna, Fountain (CR42) 2017; 8
Hinshaw, Shevde (CR51) 2019; 79
Zhang, Zhu, Liu (CR21) 2020; 158
Chen, Xiang, Ding, Cao (CR107) 2016; 17
Hevia, Castro, Pinto, Reyna-Jeldes, Rodríguez-Tirado, Robles-Planells, Ramírez-Rivera, Madariaga, Gutierrez, López, Barra, de la Fuente-Ortega, Bernal, Coddou (CR39) 2019; 10
Casola, Perucho, Tripodo, Sindaco, Ponzoni, Facchetti (CR61) 2019; 288
Zahran, Mohammed Saleh, Sayed, Rayan, Ali, Hetta (CR91) 2018; 22
Burnstock, Knight (CR10) 2018; 14
Monti, Tampucci, Zucchetti, Granchi, Minutolo, Piras (CR77) 2018; 35
Rivera, Vanzulli, Butt (CR114) 2016; 17
Amoroso, Capece, Rotondo, Cangelosi, Ferracin, Franceschini, Raffaghello, Pistoia, Varesio, Adinolfi (CR141) 2015; 34
De Marchi, Orioli, Pegoraro (CR160) 2019; 38
Di Virgilio (CR28) 2015; 22
Draganov, Gopalakrishna-Pillai, Chen, Zuckerman, Moeller, Wang, Ann, Lee (CR137) 2015; 5
Sun (CR133) 2010; 41
Lambertucci, Dal Ben, Buccioni (CR158) 2015; 22
Yang, Gao (CR3) 2017; 126
Liñán-Rico, Wunderlich, Enneking, Tso, Grants, Williams, Otey, Michel, Schemann, Needleman, Harzman, Christofi (CR157) 2015; 95
DeWitt, Smith, Schoch (CR87) 2018; 7
Farrell, Gadeock, Pupovac (CR9) 1800; 2010
Zhang, Cheng, Li, Wu, Yang (CR134) 2019; 145
Zheng, Zhang, Yang, Zhu, Zhou, Yu, Hou, Xiao, He, Wang (CR55) 2014; 452
Broers, Ramaekers (CR47) 2014; 773
Valipour, Velaei, Abedelahi, Karimipour, Darabi, Charoudeh (CR94) 2019; 234
Yan, Li, Liang, Tomić, Stojilkovic (CR26) 2008; 132
CR169
Riemann, Reime, Thews (CR71) 2017; 977
Kobayashi, Enomoto, Woods, Burt, Takahashi, Worthley, Takahashi, Worthley (CR111) 2019; 16
Zhang, Zhu, Liu (CR11) 2020; 155
Humbert, Guery, Brighouse, Lemeille, Hugues (CR72) 2018; 78
Wang, Green, Choi, Gijón, Kennedy, Johnson, Liao, Lang, Kryczek, Sell, Xia, Zhou, Li, Li, Li, Wei, Vatan, Zhang, Szeliga, Gu, Liu, Lawrence, Lamb, Tanno, Cieslik, Stone, Georgiou, Chan, Chinnaiyan, Zou (CR82) 2019; 569
Bian, Sun, Bai, Zhang, Li, Enjyoji, Junger, Robson, Wu (CR138) 2013; 8
Slater, Danieletto, Gidley-Baird, Teh, Barden (CR173) 2004; 44
Kalluri (CR109) 2016; 16
Meurer, Do, Sadowski, Held (CR116) 2017; 223
Burnstock (CR29) 2017; 16
Kawate (CR16) 2017; 1051
Ghalali, Wiklund, Zheng, Stenius, Högberg (CR164) 2014; 35
Bianchi, Vuerich, Pellegatti, Marimpietri, Emionite, Marigo, Bronte, Di Virgilio, Pistoia, Raffaghello (CR97) 2014; 5
Qian, Xiao, Hu, Sun, Yin, Zhu (CR136) 2017; 64
Danai, Babic, Rosenthal, Dennstedt, Muir, Lien, Mayers, Tai, Lau, Jones-Sali, Prado, Petersen, Takahashi, Sugimoto, Yeh, Lopez, Bardeesy, Fernandez-del Castillo, Liss, Koong, Bui, Yuan, Welch, Brais, Kulke, Dennis, Clish, Wolpin, Vander Heiden (CR46) 2018; 558
Dai, Radin, Leonardi (CR119) 2019; 71
Hu, Huang, Wang (CR76) 2016; 36
Wing, Tanaka, Sakaguchi (CR88) 2019; 50
Gu, Li, Zhao, Liu, Chu, Zang, Liu, Ning, Zhao (CR171) 2010; 38
Vázquez-Cuevas, Martínez-Ramírez, Robles-Martínez, Garay, García-Carrancá, Pérez-Montiel, Castañeda-García, Arellano (CR167) 2014; 115
Burnstock (CR15) 2016; 12
Hofman, Cherfils-Vicini, Bazin, Ilie, Juhel, Hebuterne, Gilson, Schmid-Alliana, Boyer, Adriouch, Vouret-Craviari (CR162) 2015; 75
Fang, Wang, Huang, Sun, Cheng, Tzeng (CR101) 2018; 89
CR132
Zhang, Meng, He (CR168) 2009; 41
Tsuzuki, Ase, Séguéla, Nakatsuka, Wang, She, Gu (CR153) 2003; 89
Koka, Mundre, Rangarajan, Chandramohan, Subramanian, Dhanasekaran (CR65) 2018; 45
Zong, Li, Ye (CR93) 2019; S0141-8130
Ostroumov, Fekete-Drimusz, Saborowski, Kühnel, Woller (CR85) 2018; 75
North (CR14) 2016; 371
Groth, Hu, Weber (CR96) 2019; 120
Roland, Bradley (CR150) 2014; 22
Hope, Greenlee, King (CR37) 2018; 24
Asiaf, Ahmad, Arjumand, Zargar (CR52) 2018; 1699
Kumar, Patel, Tcyganov, Gabrilovich (CR44) 2016; 37
Hajizadeh, Okoye, Esmaily, Ghasemi Chaleshtari, Masjedi, Azizi, Irandoust, Ghalamfarsa, Jadidi-Niaragh (CR62) 2019; 237
Adinolfi, Capece, Franceschini, Falzoni, Giuliani, Rotondo, Sarti, Bonora, Syberg, Corigliano, Pinton, Jorgensen, Abelli, Emionite, Raffaghello, Pistoia, Di Virgilio (CR99) 2015; 75
Falk, Schwab, Frøsig-Jørgensen, Clausen, Dickenson, Heegaard (CR172) 2015; 291
Cho, Seo, Loke, Kim, Oh, Kim, Soh, Kim, Lee, Kim, Min, Jung, Williams (CR110) 2018; 24
Huang, Chen, Wu, Ouyang, Chen, Li, Liu, Su, Lin, Yao (CR54) 2013; 8
Krysko, Garg, Kaczmarek, Krysko, Agostinis, Vandenabeele (CR120) 2012; 12
Asif, Khalid, Manzoor, Ahmad, Rehman (CR129) 2019; 15
Kishton, Sukumar, Restifo (CR84) 2017; 26
Tian, Shen, Li, Wang, Wang (CR1) 2019; 12
Feng, Sun, Csizmadia, Han, Bian, Murakami, Wang, Robson, Wu (CR13) 2011; 13
Boldrini, Giordano, Alì, Servadio, Pelliccioni, Niccoli, Mussi, Fontanini (CR17) 2014; 13
Rangarajan, Mariuzza (CR86) 2014; 71
Schmid, Evans (CR23) 2019; 81
Lu, Tan, Cai (CR67) 2015; 356
Kalluri (CR102) 2016; 126
Whiteside (CR103) 2016; 74
Xia, Yu, Tang (CR135) 2015; 34
Mo, Jiang, DiSanto, Tai, Gu (CR125) 2014; 5
Coutinho-Silva, Stahl, Cheung, de Campos, de Oliveira Souza, Ojcius, Burnstock (CR147) 2005; 288
Nörenberg, Plötz, Sobottka, Chubanov, Mittermeier, Kalwa, Aigner, Schaefer (CR151) 2016; 147
Salaro, Rambaldi, Falzoni, Amoroso, Franceschini, Sarti, Bonora, Cavazzini, Rigolin, Ciccone, Audrito, Deaglio, Pelegrin, Pinton, Cuneo, di Virgilio (CR159) 2016; 6
Duan, Neary (CR25) 2006; 54
Cho, Jung, Jung, Kim, Ko, Park, Kim (CR154) 2013; 70
Ferrari, Fallahi, Galdiero (CR80) 2019; 20
Mantovani, Marchesi, Malesci, Laghi, Allavena (CR92) 2017; 14
Qian, Chen, Zhu, Yu, Zhang, Feng, Tang, Hu, Sun, Lu, Xiao, Shen, Gu (CR124) 2016; 6
Bae, Lee, Shin, Lee, Jahng, Park (CR36) 2017; 8
Schmid, Kübler, Korcan Ayata, Lazar, Haager, Hoßfeld, Meyer, Cicko, Elze, Wiesemann, Zissel, Passlick, Idzko (CR143) 2015; 90
Zhang, Dang, Tian, Zhu, Liu, Tian, Su, Ni, Xu, Lu, Tao, Li, Zhao, Zhao, Yang, Sun, Teng, Lu (CR75) 2017; 9
Di Virgilio, Sarti, Falzoni (CR8) 2018; 18
Boison, Yegutkin (CR6) 2019; 36
Adinolfi, Capece, Amoroso, Marchi, Franceschini (CR40) 2015; 22
Chen, Feng, Yang, Yang, Ru, Liao, Wang, Lin, Ren, Zheng (CR12) 2014; 446
Thunberg, Tobin, Johnson, Söderberg, Padyukov, Hultdin, Klareskog, Enblad, Sundström, Roos, Rosenquist (CR19) 2002; 360
Bele, Fabbretti (CR32) 2015; 22
Blanc, Hans, Tran, Granier, Saldman, Anson, Oudard, Tartour (CR43) 2018; 9
Qian, Wang, Liu, Li, Colvin, Tong, Wu, Chen (CR122) 2014; 351
Mistafa, Stenius (CR152) 2009; 78
Egelston, Avalos, Tu (CR79) 2019; 4
Soto, Garcia-Guzman, Gomez-Hernandez, Hollmann, Karschin, Stuhmer (CR30) 1996; 93
Jelassi, Chantôme, Alcaraz-Pérez, Baroja-Mazo, Cayuela, Pelegrin, Surprenant, Roger (CR56) 2011; 30
Tanaka, Sakaguchi (CR89) 2017; 27
Vlasova-St Louis, Bohjanen (CR48) 2017; 33
Greening, Gopal, Xu, Simpson, Chen (CR105) 2015; 40
Wang, Huang, Zhao, Pu, Li, Deng, Lin (CR126) 2016; 4
Kim, Kim (CR78) 2016; 92
Choi, Ji, Ko, Cho, Lee (CR131) 2018; 47
Roger, Jelassi, Couillin (CR127) 1848; 2015
Dubyak (CR4) 2019; 629
Winkelmann, Thompson, Neuland, Jaramillo, Fois, Schmidt, Wittekindt, Han, Tuvim, Dickey, Dietl, Frick (CR27) 2019; 316
Alissafi, Hatzioannou, Legaki, Varveri, Verginis (CR81) 2019; 104
Lee, Bardini, Burnstock (CR34) 2000; 163
Chen, Zhang, Zhang, Zhang, Yang, Li, He (CR155) 2013; 45
Ji, Mayernik, Moin, Sloane (CR2) 2019; 38
Brisson, Reshkin, Goré, Roger (CR69) 2012; 91
Zhang, Yu (CR106) 1871; 2019
Li, Li, Zhi (CR108) 2019; 17
Gajewski, Schreiber, Fu (CR73) 2013; 14
García-Venzor, Mandujano-Tinoco, Lizarraga, Zampedri, Krötzsch, Salgado, Dávila-Borja, Encarnación-Guevara, Melendez-Zajgla, Maldonado (CR70) 2019; 1866
Burnstock (CR33) 2015; 22
Zhang, Ding, Wang (CR130) 2019; 64
Ni, Ma, Qu, Wu, Hao, Wang, Lu, Yang, Erben, Qin (CR60) 2017; 242
Sagar, Vatapalli, Lysy, Pamarthy, Anker, Rodriguez, Han, Unno, Stadler, Catalona, Hussain, Gill, Abdulkadir (CR121) 2019; 10
Lertsuwan, Ruchirawat (CR117) 2017; 37
Khalid, Manzoor, Ahmad, Asif, Bangash, Latif, Jaleel (CR144) 2018; 45
Arneth (CR50) 2019; 56
Salewskij, Rieger, Hager (CR115) 2019; 26
Guo, Trautmann, Schluesener (CR142) 2004; 152
Adinolfi, Raffaghello, Giuliani, Cavazzini, Capece, Chiozzi, Bianchi, Kroemer, Pistoia, di Virgilio (CR161) 2012; 72
Martins, Tesniere, Kepp, Michaud, Schlemmer, Senovilla, Séror, Métivier, Perfettini, Zitvogel, Kroemer (CR123) 2009; 8
Su, Chen, Yao (CR113) 2018; 172
Denton, Roberts, Fearon (CR45) 2018; 1060
Shabbir, Ryten, Thompson, Mikhailidis, Burnstock (CR148) 2008; 101
Ralevic (CR20) 2015; 22
Yao, Fan, Yuan, Takagi, Liu, Han, Ren, Liu (CR98) 2019; 19
Ali, Alfarouk, Reshkin, Ibrahim (CR74) 2017; 17
Gorodeski (CR128) 2009; 13
Zhao, Gao, Weng, Liu (CR104) 2017; 20
Aymeric, Apetoh, Ghiringhelli, Tesniere, Martins, Kroemer, Smyth, Zitvogel (CR7) 2010; 70
Jeong, Zheng, Wang (CR38) 1869; 2018
Hashemi Goradel, Najafi, Salehi, Farhood, Mortezaee (CR112) 2019; 234
Duong, Erdes, Hebeisen, Rufer (CR83) 2019; 7
Joseph, Harishankar, Pillai, Devi (CR63) 2018; 80
de Andrade, Bian, Savio (CR139) 2017; 8
Al-Shukaili, Al-Kaabi, Hassan (CR18) 2011; 38
Azimi, Beilby, Davis, Marcial, Kenny, Thompson, Roberts-Thomson, Monteith (CR146) 2016; 10
Lämmer, Beck, Grummich, Förschler, Krügel, Kahn, Schneider, Illes, Franke, Krügel (CR156) 2011; 6
Schneider, Glaser, Lameu, Abdelbaset-Ismail, Sellers, Moniuszko, Ulrich, Ratajczak (CR170) 2015; 14
Wei, Ryu, Choi, McLarnon (CR100) 2008; 260
Lee, Woo, Yoo (CR118) 2019; 24
Hattori, Gouaux (CR24) 2012; 485
Gómez-Villafuertes, del Puerto, Díaz-Hernández, Bustillo, Díaz-Hernández, Huerta, Artalejo, Garrido, Miras-Portugal (CR145) 2009; 276
He, Taylor, Fourgeaud, Bhattacharya (CR31) 2017; 14
Fu, McCormick, Qi, Luo, Zhou, Li, Wang, Gibbons, Abdul-Karim, Gorodeski (CR57) 2009; 9
Koch-Nolte, Eichhoff, Pinto-Espinoza, Schwarz, Schäfer, Menzel, Haag, Demeules, Gondé, Adriouch (CR41) 2019; 47
Parks, Cormerais, Pouysségur (CR59) 2017; 595
Park, Williams, Lee, Lee, Lee, Ko, Lee, Kim, Lee, Abdelrahman, Müller, Ju
HY Lee (9761_CR34) 2000; 163
WS DeWitt 3rd (9761_CR87) 2018; 7
WJ Zhang (9761_CR11) 2020; 155
A Liñán-Rico (9761_CR157) 2015; 95
WJ Zhang (9761_CR21) 2020; 158
JH Chen (9761_CR107) 2016; 17
H Cho (9761_CR110) 2018; 24
D Ostroumov (9761_CR85) 2018; 75
S Roger (9761_CR127) 1848; 2015
H Kobayashi (9761_CR111) 2019; 16
KM Fang (9761_CR101) 2018; 89
CF Hu (9761_CR76) 2016; 36
N Hashemi Goradel (9761_CR112) 2019; 234
A Rivera (9761_CR114) 2016; 17
T Kawate (9761_CR16) 2017; 1051
K Tsuzuki (9761_CR153) 2003; 89
W Fu (9761_CR57) 2009; 9
A Solini (9761_CR140) 2015; 6
M Hattori (9761_CR24) 2012; 485
S Casola (9761_CR61) 2019; 288
C Lambertucci (9761_CR158) 2015; 22
X Tian (9761_CR1) 2019; 12
M Yao (9761_CR98) 2019; 19
N Shimasaki (9761_CR95) 2020; 19
I Martins (9761_CR123) 2009; 8
D Boison (9761_CR6) 2019; 36
I Vlasova-St Louis (9761_CR48) 2017; 33
S Su (9761_CR113) 2018; 172
G Burnstock (9761_CR15) 2016; 12
R Coutinho-Silva (9761_CR147) 2005; 288
R Schmid (9761_CR23) 2019; 81
SK Parks (9761_CR59) 2017; 595
LQ Gu (9761_CR171) 2010; 38
S Yang (9761_CR3) 2017; 126
S Zong (9761_CR93) 2019; S0141-8130
F Qian (9761_CR136) 2017; 64
M Shabbir (9761_CR148) 2008; 101
S Chen (9761_CR12) 2014; 446
Y He (9761_CR31) 2017; 14
F Meurer (9761_CR116) 2017; 223
R Gómez-Villafuertes (9761_CR145) 2009; 276
S Falk (9761_CR172) 2015; 291
JL Broers (9761_CR47) 2014; 773
W Nörenberg (9761_CR151) 2016; 147
F Amoroso (9761_CR141) 2015; 34
Y Zhang (9761_CR130) 2019; 64
JB Wing (9761_CR88) 2019; 50
DV Krysko (9761_CR120) 2012; 12
X Zhang (9761_CR168) 2009; 41
NR Jørgensen (9761_CR22) 2015; 22
V Kumar (9761_CR44) 2016; 37
Y Zhang (9761_CR75) 2017; 9
A Riemann (9761_CR71) 2017; 977
Y Qian (9761_CR122) 2014; 351
L Brisson (9761_CR69) 2012; 91
I Azimi (9761_CR146) 2016; 10
RA North (9761_CR14) 2016; 371
C Ni (9761_CR60) 2017; 242
SH Sun (9761_CR133) 2010; 41
MN Duong (9761_CR83) 2019; 7
M Slater (9761_CR173) 2004; 44
AM Zahran (9761_CR91) 2018; 22
TF Gajewski (9761_CR73) 2013; 14
A Ghalali (9761_CR164) 2014; 35
F Hajizadeh (9761_CR62) 2019; 237
K Ji (9761_CR2) 2019; 38
C Qian (9761_CR124) 2016; 6
G Burnstock (9761_CR33) 2015; 22
T Alissafi (9761_CR81) 2019; 104
A Mantovani (9761_CR92) 2017; 14
L Boldrini (9761_CR17) 2014; 13
L Zhang (9761_CR106) 1871; 2019
K Chen (9761_CR155) 2013; 45
JM Hope (9761_CR37) 2018; 24
J Kim (9761_CR49) 2016; 2016
W Wang (9761_CR82) 2019; 569
A Tanaka (9761_CR89) 2017; 27
E Adinolfi (9761_CR99) 2015; 75
JP Joseph (9761_CR63) 2018; 80
I Ali (9761_CR74) 2017; 17
A Al-Shukaili (9761_CR18) 2011; 38
B Arneth (9761_CR50) 2019; 56
G Burnstock (9761_CR29) 2017; 16
V Sagar (9761_CR121) 2019; 10
JR Gever (9761_CR35) 2006; 452
AB Lämmer (9761_CR156) 2011; 6
L Boldrini (9761_CR53) 2015; 9
M Humbert (9761_CR72) 2018; 78
S Schmid (9761_CR143) 2015; 90
E Takai (9761_CR165) 2014; 10
Y Huang (9761_CR58) 2017; 60
AE Denton (9761_CR45) 2018; 1060
Z Yan (9761_CR26) 2008; 132
VE Mpakou (9761_CR90) 2017; 60
R Kalluri (9761_CR102) 2016; 126
C Blanc (9761_CR43) 2018; 9
VE Winkelmann (9761_CR27) 2019; 316
JH Choi (9761_CR131) 2018; 47
B Jelassi (9761_CR56) 2011; 30
9761_CR132
D Monti (9761_CR77) 2018; 35
DW Greening (9761_CR105) 2015; 40
TL Whiteside (9761_CR103) 2016; 74
T Bele (9761_CR32) 2015; 22
JY Bae (9761_CR36) 2017; 8
P Koka (9761_CR65) 2018; 45
W Wei (9761_CR100) 2008; 260
C Li (9761_CR108) 2019; 17
F Di Virgilio (9761_CR28) 2015; 22
SM Ferrari (9761_CR80) 2019; 20
Y Zhang (9761_CR134) 2019; 145
E Salaro (9761_CR159) 2016; 6
CA Egelston (9761_CR79) 2019; 4
L Aymeric (9761_CR7) 2010; 70
A García-Venzor (9761_CR70) 2019; 1866
LH Guo (9761_CR142) 2004; 152
S Loi (9761_CR174) 2013; 110
G Bianchi (9761_CR97) 2014; 5
P Hofman (9761_CR162) 2015; 75
O Mistafa (9761_CR152) 2009; 78
AW Farrell (9761_CR9) 1800; 2010
J Lu (9761_CR67) 2015; 356
M Khalid (9761_CR144) 2018; 45
E Adinolfi (9761_CR40) 2015; 22
J Lertsuwan (9761_CR117) 2017; 37
A Asiaf (9761_CR52) 2018; 1699
DC Hinshaw (9761_CR51) 2019; 79
J Xia (9761_CR135) 2015; 34
F Di Virgilio (9761_CR8) 2018; 18
PJ Lee (9761_CR118) 2019; 24
D Draganov (9761_CR137) 2015; 5
V Ralevic (9761_CR20) 2015; 22
R Mo (9761_CR125) 2014; 5
S Duan (9761_CR25) 2006; 54
L Stokes (9761_CR42) 2017; 8
K Dai (9761_CR119) 2019; 71
JH Cho (9761_CR154) 2013; 70
F Koch-Nolte (9761_CR41) 2019; 47
L Zheng (9761_CR55) 2014; 452
S Bian (9761_CR138) 2013; 8
R Kalluri (9761_CR109) 2016; 16
S Jeong (9761_CR38) 1869; 2018
E De Marchi (9761_CR160) 2019; 38
MJ Hevia (9761_CR39) 2019; 10
GR Dubyak (9761_CR4) 2019; 629
H Xiao (9761_CR68) 2003; 100
LV Danai (9761_CR46) 2018; 558
RJ Kishton (9761_CR84) 2017; 26
G Burnstock (9761_CR10) 2018; 14
APB Albuquerque (9761_CR66) 2018; 399
C Zhao (9761_CR104) 2017; 20
K Salewskij (9761_CR115) 2019; 26
WJ Zhang (9761_CR5) 2020; 125
M Khan (9761_CR149) 2019; 260
WW Tong (9761_CR64) 2018; 53
L Feng (9761_CR13) 2011; 13
FG Vázquez-Cuevas (9761_CR167) 2014; 115
E Adinolfi (9761_CR161) 2012; 72
L Brisson (9761_CR163) 2020; 12
NJ Roland (9761_CR150) 2014; 22
B Valipour (9761_CR94) 2019; 234
GH Wang (9761_CR126) 2016; 4
G Schneider (9761_CR170) 2015; 14
JH Park (9761_CR166) 2016; 59
9761_CR169
MP de Andrade (9761_CR139) 2017; 8
C Groth (9761_CR96) 2019; 120
GI Gorodeski (9761_CR128) 2009; 13
F Soto (9761_CR30) 1996; 93
U Thunberg (9761_CR19) 2002; 360
S Rangarajan (9761_CR86) 2014; 71
A Asif (9761_CR129) 2019; 15
S Huang (9761_CR54) 2013; 8
SR Kim (9761_CR78) 2016; 92
References_xml – volume: 41
  start-page: 351
  year: 2010
  end-page: 355
  ident: CR133
  article-title: Roles of P2X7 receptor in glial and neuroblastoma cells: the therapeutic potential of P2X7 receptor antagonists
  publication-title: Mol Neurobiol
  doi: 10.1007/s12035-010-8120-x
– volume: 14
  start-page: 201
  year: 2015
  ident: CR170
  article-title: Extracellular nucleotides as novel, underappreciated pro-metastatic factors that stimulate purinergic signaling in human lung cancer cells
  publication-title: Mol Cancer
  doi: 10.1186/s12943-015-0469-z
– volume: 33
  start-page: 83
  year: 2017
  end-page: 93
  ident: CR48
  article-title: Post-transcriptional regulation of cytokine and growth factor signaling in cancer
  publication-title: Cytokine Growth Factor Rev
  doi: 10.1016/j.cytogfr.2016.11.004
– volume: 95
  start-page: 83
  year: 2015
  end-page: 99
  ident: CR157
  article-title: Neuropharmacology of purinergic receptors in human submucous plexus: involvement of P2X , P2X , P2X channels, P2Y and A metabotropic receptors in neurotransmission
  publication-title: Neuropharmacology.
  doi: 10.1016/j.neuropharm.2015.02.014
– volume: 72
  start-page: 2957
  year: 2012
  end-page: 2969
  ident: CR161
  article-title: Expression of P2X7 receptor increases in vivo tumor growth
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-11-1947
– volume: 44
  start-page: 206
  year: 2004
  end-page: 215
  ident: CR173
  article-title: Early prostate cancer detected using expression of non-functional cytolytic P2X7 receptors
  publication-title: Histopathology.
  doi: 10.1111/j.0309-0167.2004.01798.x
– volume: 38
  start-page: 389
  year: 2011
  end-page: 396
  ident: CR18
  article-title: P2X7 receptor gene polymorphism analysis in rheumatoid arthritis
  publication-title: Int J Immunogenet
  doi: 10.1111/j.1744-313X.2011.01019.x
– volume: 152
  start-page: 67
  year: 2004
  end-page: 72
  ident: CR142
  article-title: Expression of P2X4 receptor in rat C6 glioma by tumor-associated macrophages and activated microglia
  publication-title: J Neuroimmunol
  doi: 10.1016/j.jneuroim.2004.04.005
– volume: 18
  start-page: 601
  year: 2018
  end-page: 618
  ident: CR8
  article-title: Extracellular ATP and P2 purinergic signalling in the tumour microenvironment
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-018-0037-0
– volume: 132
  start-page: 563
  year: 2008
  end-page: 573
  ident: CR26
  article-title: The P2X7 receptor channel pore dilates under physiological ion conditions
  publication-title: J Gen Physiol
  doi: 10.1085/jgp.200810059
– volume: 4
  start-page: 130000
  year: 2019
  ident: CR79
  article-title: Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.130000
– volume: 90
  start-page: 516
  year: 2015
  end-page: 521
  ident: CR143
  article-title: Altered purinergic signaling in the tumor associated immunologic microenvironment in metastasized non-small-cell lung cancer
  publication-title: Lung Cancer
  doi: 10.1016/j.lungcan.2015.10.005
– volume: 64
  start-page: 61
  year: 2017
  end-page: 68
  ident: CR136
  article-title: High expression of P2X7R is an independent postoperative indicator of poor prognosis in colorectal cancer
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2017.03.019
– volume: 38
  start-page: 3636
  year: 2019
  end-page: 3650
  ident: CR160
  article-title: The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment
  publication-title: Oncogene.
  doi: 10.1038/s41388-019-0684-y
– volume: 26
  start-page: 94
  year: 2017
  end-page: 109
  ident: CR84
  article-title: Metabolic regulation of T cell longevity and function in tumor immunotherapy
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2017.06.016
– volume: 50
  start-page: 302
  year: 2019
  end-page: 316
  ident: CR88
  article-title: Human FOXP3+ regulatory T cell heterogeneity and function in autoimmunity and cancer
  publication-title: Immunity.
  doi: 10.1016/j.immuni.2019.01.020
– volume: 2015
  start-page: 2584
  year: 1848
  end-page: 2602
  ident: CR127
  article-title: Understanding the roles of the P2X7 receptor in solid tumour progression and therapeutic perspectives
  publication-title: Biochim Biophys Acta
– volume: 92
  start-page: 502
  year: 2016
  end-page: 507
  ident: CR78
  article-title: Effects of chronic exposure to acidic environment on the response of tumor cells to radiation
  publication-title: Int J Radiat Biol
  doi: 10.1080/09553002.2016.1206222
– volume: 89
  start-page: 199
  year: 2018
  end-page: 211
  ident: CR101
  article-title: Expression of macrophage inflammatory protein-1α and monocyte chemoattractant protein-1 in glioma-infiltrating microglia: involvement of ATP and P2X receptor
  publication-title: J Neurosci Res
  doi: 10.1002/jnr.22538
– volume: 59
  start-page: 7410
  year: 2016
  end-page: 7430
  ident: CR166
  article-title: Potent suppressive effects of 1-piperidinylimidazole based novel P2X7 receptor antagonists on cancer cell migration and invasion
  publication-title: J Med Chem
  doi: 10.1021/acs.jmedchem.5b01690
– volume: 22
  start-page: 866
  year: 2015
  end-page: 877
  ident: CR28
  article-title: P2X receptors and inflammation
  publication-title: Curr Med Chem
  doi: 10.2174/0929867322666141210155311
– volume: 2010
  start-page: 1173
  year: 1800
  end-page: 1182
  ident: CR9
  article-title: P2X7 receptor activation induces cell death and CD23 shedding in human RPMI 8226 multiple myeloma cells
  publication-title: Biochim Biophys Acta
– volume: 163
  start-page: 2002
  year: 2000
  end-page: 2007
  ident: CR34
  article-title: Distribution of P2X receptors in the urinary bladder and the ureter of the rat
  publication-title: J Urol
  doi: 10.1016/S0022-5347(05)67618-5
– volume: 22
  start-page: 915
  year: 2015
  end-page: 928
  ident: CR158
  article-title: Medicinal chemistry of P2X receptors: agonists and orthosteric antagonists
  publication-title: Curr Med Chem
  doi: 10.2174/0929867321666141215093513
– volume: 47
  start-page: 643
  year: 2018
  end-page: 651
  ident: CR131
  article-title: Activating P2X7 receptors increases proliferation of human pancreatic cancer cells via ERK1/2 and JNK
  publication-title: Pancreas.
  doi: 10.1097/MPA.0000000000001055
– volume: 6
  start-page: e19983
  year: 2011
  ident: CR156
  article-title: The P2 receptor antagonist PPADS supports recovery from experimental stroke in vivo
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0019983
– ident: CR132
– volume: 70
  start-page: 811
  year: 2013
  end-page: 830
  ident: CR154
  article-title: Design and synthesis of potent and selective P2X receptor antagonists derived from PPADS as potential pain modulators
  publication-title: Eur J Med Chem
  doi: 10.1016/j.ejmech.2013.10.026
– volume: 38
  start-page: 103
  year: 2019
  end-page: 112
  ident: CR2
  article-title: Acidosis and proteolysis in the tumor microenvironment
  publication-title: Cancer Metastasis Rev
  doi: 10.1007/s10555-019-09796-3
– volume: 38
  start-page: 276
  year: 2010
  end-page: 282
  ident: CR171
  article-title: Association of XIAP and P2X7 receptor expression with lymph node metastasis in papillary thyroid carcinoma
  publication-title: Endocrine.
  doi: 10.1007/s12020-010-9384-7
– volume: 36
  start-page: 455
  year: 2016
  end-page: 461
  ident: CR76
  article-title: Upregulation of ABCG2 via the PI3K-Akt pathway contributes to acidic microenvironment-induced cisplatin resistance in A549 and LTEP-a-2 lung cancer cells
  publication-title: Oncol Rep
  doi: 10.3892/or.2016.4827
– volume: 260
  start-page: 79
  year: 2008
  end-page: 87
  ident: CR100
  article-title: Expression and function of the P2X(7) receptor in rat C6 glioma cells
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2007.10.025
– volume: 34
  start-page: 5240
  year: 2015
  end-page: 5251
  ident: CR141
  article-title: The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma
  publication-title: Oncogene.
  doi: 10.1038/onc.2014.444
– volume: 288
  start-page: 198
  year: 2019
  end-page: 213
  ident: CR61
  article-title: The B-cell receptor in control of tumor B-cell fitness: biology and clinical relevance
  publication-title: Immunol Rev
  doi: 10.1111/imr.12738
– volume: 5
  start-page: 3364
  year: 2014
  ident: CR125
  article-title: ATP-triggered anticancer drug delivery
  publication-title: Nat Commun
  doi: 10.1038/ncomms4364
– volume: 14
  start-page: 135
  year: 2017
  ident: CR31
  article-title: The role of microglial P2X7: modulation of cell death and cytokine release
  publication-title: J Neuroinflammation
  doi: 10.1186/s12974-017-0904-8
– volume: 6
  start-page: 1053
  year: 2016
  end-page: 1064
  ident: CR124
  article-title: ATP-responsive and near-infrared-emissive nanocarriers for anticancer drug delivery and real-time imaging
  publication-title: Theranostics.
  doi: 10.7150/thno.14843
– volume: 5
  start-page: 16222
  year: 2015
  ident: CR137
  article-title: Modulation of P2X4/P2X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death
  publication-title: Sci Rep
  doi: 10.1038/srep16222
– volume: 75
  start-page: 635
  year: 2015
  end-page: 644
  ident: CR99
  article-title: Accelerated tumor progression in mice lacking the ATP receptor P2X7
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-14-1259
– volume: 22
  start-page: 101
  year: 2014
  end-page: 108
  ident: CR150
  article-title: The role of surgery in the palliation of head and neck cancer
  publication-title: Curr Opin Otolaryngol Head Neck Surg
  doi: 10.1097/MOO.0000000000000031
– volume: 60
  start-page: 1114
  year: 2017
  end-page: 1124
  ident: CR58
  article-title: Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?
  publication-title: Sci China Life Sci
  doi: 10.1007/s11427-017-9178-y
– volume: 1051
  start-page: 55
  year: 2017
  end-page: 69
  ident: CR16
  article-title: P2X receptor activation
  publication-title: Adv Exp Med Biol
  doi: 10.1007/5584_2017_55
– volume: 452
  start-page: 513
  year: 2006
  end-page: 537
  ident: CR35
  article-title: Pharmacology of P2X channels
  publication-title: Pflugers Arch
  doi: 10.1007/s00424-006-0070-9
– volume: 34
  start-page: 103
  year: 2015
  end-page: 110
  ident: CR135
  article-title: P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway
  publication-title: Oncol Rep
  doi: 10.3892/or.2015.3979
– volume: 71
  start-page: 1184
  year: 2019
  end-page: 1189
  ident: CR119
  article-title: PINK1 depletion sensitizes non-small cell lung cancer to glycolytic inhibitor 3-bromopyruvate: involvement of ROS and mitophagy
  publication-title: Pharmacol Rep
  doi: 10.1016/j.pharep.2019.08.002
– volume: 242
  start-page: 334
  year: 2017
  end-page: 346
  ident: CR60
  article-title: Accelerated tumour metastasis due to interferon-γ receptor-mediated dissociation of perivascular cells from blood vessels
  publication-title: J Pathol
  doi: 10.1002/path.4907
– volume: 17
  start-page: 1829
  year: 2016
  end-page: 1833
  ident: CR114
  article-title: A central role for ATP signalling in glial interactions in the CNS
  publication-title: Curr Drug Targets
  doi: 10.2174/1389450117666160711154529
– volume: 91
  start-page: 847
  year: 2012
  end-page: 860
  ident: CR69
  article-title: pH regulators in invadosomal functioning: proton delivery for matrix tasting
  publication-title: Eur J Cell Biol
  doi: 10.1016/j.ejcb.2012.04.004
– volume: 5
  year: 2014
  ident: CR97
  article-title: ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2014.109
– volume: 2016
  start-page: 6058147
  year: 2016
  ident: CR49
  article-title: Tumor-associated macrophages and neutrophils in tumor microenvironment
  publication-title: Mediat Inflamm
– volume: 16
  start-page: 582
  year: 2016
  end-page: 598
  ident: CR109
  article-title: The biology and function of fibroblasts in cancer
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc.2016.73
– volume: 9
  start-page: 1722
  year: 2018
  ident: CR43
  article-title: Targeting resident memory T cells for cancer immunotherapy
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.01722
– volume: 41
  start-page: 362
  year: 2009
  end-page: 369
  ident: CR168
  article-title: The role of P2X7 receptor in ATP-mediated human leukemia cell death: calcium influx-independent
  publication-title: Acta Biochim Biophys Sin Shanghai
  doi: 10.1093/abbs/gmp016
– volume: 595
  start-page: 2439
  year: 2017
  end-page: 2450
  ident: CR59
  article-title: Hypoxia and cellular metabolism in tumour pathophysiology
  publication-title: J Physiol
  doi: 10.1113/JP273309
– volume: 8
  year: 2013
  ident: CR138
  article-title: P2X7 integrates PI3K/AKT and AMPK-PRAS40-mTOR signaling pathways to mediate tumor cell death
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0060184
– volume: 20
  start-page: 357
  year: 2017
  end-page: 367
  ident: CR104
  article-title: Pancreatic cancer and associated exosomes
  publication-title: Cancer Biomark
  doi: 10.3233/CBM-170258
– volume: 126
  start-page: 1208
  year: 2016
  end-page: 1215
  ident: CR102
  article-title: The biology and function of exosomes in cancer
  publication-title: J Clin Invest
  doi: 10.1172/JCI81135
– volume: 104
  start-page: 102310
  year: 2019
  ident: CR81
  article-title: Balancing cancer immunotherapy and immune-related adverse events: the emerging role of regulatory T cells
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2019.102310
– volume: 22
  start-page: 845
  year: 2015
  end-page: 850
  ident: CR32
  article-title: P2X receptors, sensory neurons and pain
  publication-title: Curr Med Chem
  doi: 10.2174/0929867321666141011195351
– volume: 27
  start-page: 109
  year: 2017
  end-page: 118
  ident: CR89
  article-title: Regulatory T cells in cancer immunotherapy
  publication-title: Cell Res
  doi: 10.1038/cr.2016.151
– volume: 14
  start-page: 399
  year: 2017
  end-page: 416
  ident: CR92
  article-title: Tumour-associated macrophages as treatment targets in oncology
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/nrclinonc.2016.217
– volume: 93
  start-page: 3684
  year: 1996
  end-page: 3688
  ident: CR30
  article-title: P2X4: an ATP-activated ionotropic receptor cloned from rat brain
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.93.8.3684
– volume: 10
  start-page: 487
  year: 2014
  end-page: 497
  ident: CR165
  article-title: Autocrine signaling via release of ATP and activation of P2X7 receptor influences motile activity of human lung cancer cells
  publication-title: Purinergic Signal
  doi: 10.1007/s11302-014-9411-x
– volume: 22
  start-page: 851
  year: 2015
  end-page: 865
  ident: CR20
  article-title: P2X receptors in the cardiovascular system and their potential as therapeutic targets in disease
  publication-title: Curr Med Chem
  doi: 10.2174/0929867321666141215094050
– volume: 74
  start-page: 103
  year: 2016
  end-page: 141
  ident: CR103
  article-title: Tumor-derived exosomes and their role in cancer progression
  publication-title: Adv Clin Chem
  doi: 10.1016/bs.acc.2015.12.005
– volume: 4
  start-page: 3832
  year: 2016
  end-page: 3841
  ident: CR126
  article-title: ATP triggered drug release and DNA co-delivery systems based on ATP responsive aptamers and polyethylenimine complexes
  publication-title: J Mater Chem B
  doi: 10.1039/C5TB02764K
– volume: 125
  start-page: 109844
  year: 2020
  ident: CR5
  article-title: Effect of P2X7 receptor on tumorigenesis and its pharmacological properties
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2020.109844
– volume: 977
  start-page: 119
  year: 2017
  end-page: 124
  ident: CR71
  article-title: Hypoxia-related tumor acidosis affects MicroRNA expression pattern in prostate and breast tumor cells
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-3-319-55231-6_16
– volume: 12
  start-page: 860
  year: 2012
  end-page: 875
  ident: CR120
  article-title: Immunogenic cell death and DAMPs in cancer therapy
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3380
– volume: 37
  start-page: 208
  year: 2016
  end-page: 220
  ident: CR44
  article-title: The nature of myeloid-derived suppressor cells in the tumor microenvironment
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2016.01.004
– volume: 75
  start-page: 689
  year: 2018
  end-page: 713
  ident: CR85
  article-title: CD4 and CD8 T lymphocyte interplay in controlling tumor growth
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-017-2686-7
– volume: 40
  start-page: 72
  year: 2015
  end-page: 81
  ident: CR105
  article-title: Exosomes and their roles in immune regulation and cancer
  publication-title: Semin Cell Dev Biol
  doi: 10.1016/j.semcdb.2015.02.009
– volume: 8
  start-page: 3723
  year: 2009
  end-page: 5728
  ident: CR123
  article-title: Chemotherapy induces ATP release from tumor cells
  publication-title: Cell Cycle
  doi: 10.4161/cc.8.22.10026
– volume: 16
  start-page: 282
  year: 2019
  end-page: 295
  ident: CR111
  article-title: Cancer-associated fibroblasts in gastrointestinal cancer
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/s41575-019-0115-0
– volume: 45
  start-page: 932
  year: 2013
  end-page: 943
  ident: CR155
  article-title: ATP-P2X4 signaling mediates NLRP3 inflammasome activation: a novel pathway of diabetic nephropathy
  publication-title: Int J Biochem Cell Biol
  doi: 10.1016/j.biocel.2013.02.009
– volume: 2019
  start-page: 455
  year: 1871
  end-page: 468
  ident: CR106
  article-title: Exosomes in cancer development, metastasis, and immunity
  publication-title: Biochim Biophys Acta Rev Cancer
– volume: 22
  start-page: 902
  year: 2015
  end-page: 914
  ident: CR22
  article-title: The role of P2X receptors in bone biology
  publication-title: Curr Med Chem
  doi: 10.2174/0929867321666141215094749
– volume: 15
  start-page: 367
  year: 2019
  end-page: 374
  ident: CR129
  article-title: Role of purinergic receptors in hepatobiliary carcinoma in Pakistani population: an approach towards proinflammatory role of P2X4 and P2X7 receptors
  publication-title: Purinergic Signal
  doi: 10.1007/s11302-019-09675-0
– volume: 36
  start-page: 582
  year: 2019
  end-page: 596
  ident: CR6
  article-title: Adenosine metabolism: emerging concepts for Cancer therapy
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2019.10.007
– volume: 316
  start-page: L58
  year: 2019
  end-page: L70
  ident: CR27
  article-title: Inflammation-induced upregulation of P2X4expression augments mucin secretion in airway epithelia
  publication-title: Am J Phys Lung Cell Mol Phys
– volume: 569
  start-page: 270
  year: 2019
  end-page: 274
  ident: CR82
  article-title: CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
  publication-title: Nature.
  doi: 10.1038/s41586-019-1170-y
– volume: S0141-8130
  start-page: 36746
  year: 2019
  end-page: 36747
  ident: CR93
  article-title: Lachnum polysaccharide suppresses S180 sarcoma by boosting anti-tumor immune responses and skewing tumor-associated macrophages toward M1 phenotype
  publication-title: Int J Biol Macromol
– volume: 13
  start-page: 1313
  year: 2009
  end-page: 1332
  ident: CR128
  article-title: P2X7-mediated chemoprevention of epithelial cancers
  publication-title: Expert Opin Ther Targets
  doi: 10.1517/14728220903277249
– volume: 773
  start-page: 27
  year: 2014
  end-page: 48
  ident: CR47
  article-title: The role of the nuclear lamina in cancer and apoptosis
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-1-4899-8032-8_2
– volume: 7
  start-page: e38358
  year: 2018
  ident: CR87
  article-title: Human T cell receptor occurrence patterns encode immune history, genetic background, and receptor specificity
  publication-title: Elife.
  doi: 10.7554/eLife.38358
– volume: 6
  start-page: 28743
  year: 2015
  end-page: 28754
  ident: CR140
  article-title: Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.4926
– volume: 6
  start-page: 26280
  year: 2016
  ident: CR159
  article-title: Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death
  publication-title: Sci Rep
  doi: 10.1038/srep26280
– volume: 13
  start-page: 16
  year: 2014
  ident: CR17
  article-title: P2X7 protein expression and polymorphism in non-small cell lung cancer (NSCLC)
  publication-title: J Negat Results Biomed
  doi: 10.1186/1477-5751-13-16
– volume: 101
  start-page: 106
  year: 2008
  end-page: 112
  ident: CR148
  article-title: Purinergic receptor-mediated effects of ATP in high-grade bladder cancer
  publication-title: BJU Int
  doi: 10.1111/j.1464-410X.2007.07293.x
– volume: 53
  start-page: 469
  year: 2018
  end-page: 476
  ident: CR64
  article-title: Cancer stem cells and hypoxia-inducible factors (review)
  publication-title: Int J Oncol
– volume: 1699
  start-page: 23
  year: 2018
  end-page: 43
  ident: CR52
  article-title: MicroRNAs in breast cancer: diagnostic and therapeutic potential
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-4939-7435-1_2
– volume: 17
  start-page: 1617
  year: 2017
  end-page: 1623
  ident: CR74
  article-title: Doxycycline as potential anti-cancer agent
  publication-title: Anti Cancer Agents Med Chem
– volume: 446
  start-page: 1002
  year: 2014
  end-page: 1009
  ident: CR12
  article-title: Functional expression of P2X family receptors in macrophages is affected by microenvironment in mouse T cell acute lymphoblastic leukemia
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2014.03.048
– volume: 26
  start-page: 148091
  year: 2019
  ident: CR115
  article-title: The spatio-temporal organization of mitochondrial F1FO ATP synthase in cristae depends on its activity mode
  publication-title: Biochim Biophys Acta Bioenerg
– volume: 234
  start-page: 5683
  year: 2019
  end-page: 5699
  ident: CR112
  article-title: Cyclooxygenase-2 in cancer: a review
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.27411
– volume: 14
  start-page: 1
  year: 2018
  end-page: 18
  ident: CR10
  article-title: The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression
  publication-title: Purinergic Signal
  doi: 10.1007/s11302-017-9593-0
– volume: 155
  start-page: 19
  year: 2020
  end-page: 28
  ident: CR11
  article-title: The role and pharmacological properties of the P2X7 receptor in neuropathic pain
  publication-title: Brain Res Bull
  doi: 10.1016/j.brainresbull.2019.11.006
– volume: 45
  start-page: 2625
  year: 2018
  end-page: 2630
  ident: CR144
  article-title: Purinoceptor expression in hepatocellular virus (HCV)-induced and non-HCV hepatocellular carcinoma: an insight into the proviral role of the P2X4 receptor
  publication-title: Mol Biol Rep
  doi: 10.1007/s11033-018-4432-0
– volume: 12
  start-page: 59
  year: 2016
  end-page: 67
  ident: CR15
  article-title: P2X ion channel receptors and inflammation
  publication-title: Purinergic Signal
  doi: 10.1007/s11302-015-9493-0
– volume: 35
  start-page: 1547
  year: 2014
  end-page: 1555
  ident: CR164
  article-title: Atorvastatin prevents ATP-driven invasiveness via P2X7 and EHBP1 signaling in PTEN-expressing prostate cancer cells
  publication-title: Carcinogenesis.
  doi: 10.1093/carcin/bgu019
– volume: 7
  start-page: 284
  year: 2019
  ident: CR83
  article-title: Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes
  publication-title: J Immunother Cancer
  doi: 10.1186/s40425-019-0773-z
– volume: 47
  start-page: 110
  year: 2019
  end-page: 118
  ident: CR41
  article-title: Novel biologics targeting the P2X7 ion channel
  publication-title: Curr Opin Pharmacol
  doi: 10.1016/j.coph.2019.03.001
– volume: 8
  start-page: 291
  year: 2017
  ident: CR42
  article-title: P2X4 receptor function in the nervous system and current breakthroughs in pharmacology
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2017.00291
– volume: 291
  start-page: 93
  year: 2015
  end-page: 105
  ident: CR172
  article-title: P2X7 receptor-mediated analgesia in cancer-induced bone pain
  publication-title: Neuroscience.
  doi: 10.1016/j.neuroscience.2015.02.011
– volume: 629
  start-page: 81
  year: 2019
  end-page: 102
  ident: CR4
  article-title: Luciferase-assisted detection of extracellular ATP and ATP metabolites during immunogenic death of cancer cells
  publication-title: Methods Enzymol
  doi: 10.1016/bs.mie.2019.10.006
– volume: 13
  start-page: 206
  year: 2011
  end-page: 216
  ident: CR13
  article-title: Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate
  publication-title: Neoplasia.
  doi: 10.1593/neo.101332
– volume: 10
  start-page: 612
  year: 2019
  ident: CR39
  article-title: Differential effects of purinergic signaling in gastric cancer-derived cells through P2Y and P2X receptors
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2019.00612
– volume: 30
  start-page: 2108
  issue: 18
  year: 2011
  end-page: 2122
  ident: CR56
  article-title: P2X(7) receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness
  publication-title: Oncogene.
  doi: 10.1038/onc.2010.593
– volume: 80
  start-page: 23
  year: 2018
  end-page: 32
  ident: CR63
  article-title: Hypoxia induced EMT: a review on the mechanism of tumor progression and metastasis in OSCC
  publication-title: Oral Oncol
  doi: 10.1016/j.oraloncology.2018.03.004
– volume: 64
  start-page: 388
  year: 2019
  end-page: 394
  ident: CR130
  article-title: The role of P2X7 receptor in prognosis and metastasis of colorectal cancer
  publication-title: Adv Med Sci
  doi: 10.1016/j.advms.2019.05.002
– volume: 79
  start-page: 4557
  year: 2019
  end-page: 4566
  ident: CR51
  article-title: The tumor microenvironment innately modulates cancer progression
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-18-3962
– volume: 1060
  start-page: 99
  year: 2018
  end-page: 114
  ident: CR45
  article-title: Stromal cells in the tumor microenvironment
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-3-319-78127-3_6
– volume: 37
  start-page: 3553
  year: 2017
  end-page: 3561
  ident: CR117
  article-title: Inhibitory effects of ATP and adenosine on cholangiocarcinoma cell proliferation and motility
  publication-title: Anticancer Res
  doi: 10.21873/anticanres.11345
– volume: 399
  start-page: 661
  year: 2018
  end-page: 672
  ident: CR66
  article-title: Hypoxia and serum deprivation induces glycan alterations in triple negative breast cancer cells
  publication-title: Biol Chem
  doi: 10.1515/hsz-2018-0121
– volume: 20
  start-page: E4413
  year: 2019
  ident: CR80
  article-title: Immune and inflammatory cells in thyroid cancer microenvironment
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms20184413
– volume: 485
  start-page: 207
  year: 2012
  end-page: 212
  ident: CR24
  article-title: Molecular mechanism of ATP binding and ion channel activation in P2X receptors
  publication-title: Nature.
  doi: 10.1038/nature11010
– volume: 234
  start-page: 19352
  year: 2019
  end-page: 19365
  ident: CR94
  article-title: NK cells: an attractive candidate for cancer therapy
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.28657
– volume: 452
  start-page: 197
  year: 2014
  end-page: 204
  ident: CR55
  article-title: Regulation of the P2X7R by microRNA-216b in human breast cancer
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2014.07.101
– volume: 71
  start-page: 3059
  year: 2014
  end-page: 3068
  ident: CR86
  article-title: T cell receptor bias for MHC: co-evolution or co-receptors?
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-014-1600-9
– volume: 223
  start-page: 30
  year: 2017
  end-page: 38
  ident: CR116
  article-title: Standard Gibbs energy of metabolic reactions: II. Glucose-6-phosphatase reaction and ATP hydrolysis
  publication-title: Biophys Chem
  doi: 10.1016/j.bpc.2017.02.005
– volume: 81
  start-page: 43
  year: 2019
  end-page: 62
  ident: CR23
  article-title: ATP-gated P2X receptor channels: molecular insights into functional roles
  publication-title: Annu Rev Physiol
  doi: 10.1146/annurev-physiol-020518-114259
– volume: 89
  start-page: 3235
  year: 2003
  end-page: 3242
  ident: CR153
  article-title: TNP-ATP-resistant P2X ionic current on the central terminals and somata of rat primary sensory neurons
  publication-title: J Neurophysiol
  doi: 10.1152/jn.01171.2002
– volume: 147
  start-page: 467
  year: 2016
  end-page: 483
  ident: CR151
  article-title: TRPM7 is a molecular substrate of ATP-evoked P2X7-like currents in tumor cells
  publication-title: J Gen Physiol
  doi: 10.1085/jgp.201611595
– volume: 22
  start-page: 819
  year: 2015
  end-page: 844
  ident: CR33
  article-title: Physiopathological roles of P2X receptors in the central nervous system
  publication-title: Curr Med Chem
  doi: 10.2174/0929867321666140706130415
– volume: 2018
  start-page: 286
  year: 1869
  end-page: 292
  ident: CR38
  article-title: Nervous system and primary liver cancer
  publication-title: Biochim Biophys Acta Rev Cancer
– volume: 22
  start-page: 587
  year: 2018
  end-page: 595
  ident: CR91
  article-title: Up-regulation of regulatory T cells, CD200 and TIM3 expression in cytogenetically normal acute myeloid leukemia
  publication-title: Cancer Biomark
  doi: 10.3233/CBM-181368
– volume: 24
  start-page: E3575
  year: 2019
  ident: CR118
  article-title: Differential mechanism of ATP production occurs in response to succinylacetone in colon cancer cells
  publication-title: Molecules.
  doi: 10.3390/molecules24193575
– volume: 371
  start-page: 20150427
  year: 2016
  ident: CR14
  article-title: P2X receptors
  publication-title: Philos Trans R Soc Lond Ser B Biol Sci
  doi: 10.1098/rstb.2015.0427
– volume: 558
  start-page: 600
  year: 2018
  end-page: 604
  ident: CR46
  article-title: Altered exocrine function can drive adipose wasting in early pancreatic cancer
  publication-title: Nature.
  doi: 10.1038/s41586-018-0235-7
– volume: 19
  start-page: 216
  year: 2019
  ident: CR98
  article-title: Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell
  publication-title: BMC Complement Altern Med
  doi: 10.1186/s12906-019-2615-4
– volume: 351
  start-page: 242
  year: 2014
  end-page: 251
  ident: CR122
  article-title: Extracellular ATP is internalized by macropinocytosis and induces intracellular ATP increase and drug resistance in cancer cells
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2014.06.008
– volume: 12
  start-page: E2342
  year: 2020
  ident: CR163
  article-title: P2X7 receptor promotes mouse mammary cancer cell invasiveness and tumour progression, and is a target for anticancer treatment
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers12092342
– volume: 172
  start-page: 841
  year: 2018
  end-page: 856.e16
  ident: CR113
  article-title: CD10+GPR77+cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness
  publication-title: Cell
  doi: 10.1016/j.cell.2018.01.009
– volume: 78
  start-page: 1115
  year: 2009
  end-page: 1126
  ident: CR152
  article-title: Statins inhibit Akt/PKB signaling via P2X7 receptor in pancreatic cancer cells
  publication-title: Biochem Pharmacol
  doi: 10.1016/j.bcp.2009.06.016
– volume: 12
  start-page: 84
  year: 2019
  ident: CR1
  article-title: Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment
  publication-title: J Hematol Oncol
  doi: 10.1186/s13045-019-0772-z
– volume: 100
  start-page: 5205
  year: 2003
  end-page: 3210
  ident: CR68
  article-title: Acidic pH induces topoisomerase II-mediated DNA damage
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0935978100
– volume: 10
  start-page: 166
  year: 2016
  end-page: 178
  ident: CR146
  article-title: Altered purinergic receptor-Ca signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells
  publication-title: Mol Oncol
  doi: 10.1016/j.molonc.2015.09.006
– volume: 1866
  start-page: 118523
  year: 2019
  ident: CR70
  article-title: Microenvironment-regulated lncRNA-HAL is able to promote stemness in breast cancer cells
  publication-title: Biochim Biophys Acta, Mol Cell Res
  doi: 10.1016/j.bbamcr.2019.118523
– volume: 45
  start-page: 1653
  year: 2018
  end-page: 1662
  ident: CR65
  article-title: Uncoupling Warburg effect and stemness in CD133+ve cancer stem cells from Saos-2 (osteosarcoma) cell line under hypoxia
  publication-title: Mol Biol Rep
  doi: 10.1007/s11033-018-4309-2
– volume: 126
  start-page: 97
  year: 2017
  end-page: 108
  ident: CR3
  article-title: Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2017.05.004
– volume: 9
  start-page: 30543
  year: 2017
  end-page: 30552
  ident: CR75
  article-title: Tumor acidic microenvironment targeted drug delivery based on pHLIP-modified mesoporous organosilica nanoparticles
  publication-title: ACS Appl Mater Interfaces
  doi: 10.1021/acsami.7b10840
– volume: 276
  start-page: 5307
  year: 2009
  end-page: 5325
  ident: CR145
  article-title: Ca2+/calmodulin-dependent kinase II signalling cascade mediates P2X7 receptor-dependent inhibition of neuritogenesis in neuroblastoma cells
  publication-title: FEBS J
  doi: 10.1111/j.1742-4658.2009.07228.x
– volume: 145
  start-page: 1068
  year: 2019
  end-page: 1082
  ident: CR134
  article-title: Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling
  publication-title: Int J Cancer
  doi: 10.1002/ijc.32207
– volume: 158
  start-page: 104875
  year: 2020
  ident: CR21
  article-title: The role of P2X4 receptor in neuropathic pain and its pharmacological properties
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2020.104875
– volume: 10
  start-page: 801
  year: 2019
  ident: CR121
  article-title: EPHB4 inhibition activates ER stress to promote immunogenic cell death of prostate cancer cells
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-019-2042-y
– volume: 360
  start-page: 1935
  year: 2002
  end-page: 1939
  ident: CR19
  article-title: Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(02)11917-9
– volume: 22
  start-page: 878
  year: 2015
  end-page: 890
  ident: CR40
  article-title: Emerging roles of P2X receptors in cancer
  publication-title: Curr Med Chem
  doi: 10.2174/0929867321666141012172913
– volume: 54
  start-page: 738
  year: 2006
  end-page: 746
  ident: CR25
  article-title: P2X(7) receptors: properties and relevance to CNS function
  publication-title: Glia.
  doi: 10.1002/glia.20397
– volume: 60
  start-page: 74
  year: 2017
  end-page: 81
  ident: CR90
  article-title: Quantitative and qualitative analysis of regulatory T cells in B cell chronic lymphocytic leukemia
  publication-title: Leuk Res
  doi: 10.1016/j.leukres.2017.07.004
– volume: 288
  start-page: G1024
  year: 2005
  end-page: G1035
  ident: CR147
  article-title: P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation
  publication-title: Am J Physiol Gastrointest Liver Physiol
  doi: 10.1152/ajpgi.00211.2004
– ident: CR169
– volume: 17
  start-page: 537
  year: 2016
  end-page: 544
  ident: CR107
  article-title: Cholangiocarcinoma-derived exosomes inhibit the antitumor activity of cytokine-induced killer cells by down-regulating the secretion of tumor necrosis factor-α and perforin
  publication-title: J Zhejiang Univ Sci B
  doi: 10.1631/jzus.B1500266
– volume: 70
  start-page: 855
  year: 2010
  end-page: 858
  ident: CR7
  article-title: Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-09-3566
– volume: 260
  start-page: 43
  year: 2019
  end-page: 79
  ident: CR149
  article-title: The evolving landscape of cancer therapeutics
  publication-title: Handb Exp Pharmacol
  doi: 10.1007/164_2019_312
– volume: 78
  start-page: 3280
  year: 2018
  end-page: 3292
  ident: CR72
  article-title: Intratumoral CpG-B promotes antitumoral neutrophil, cDC, and T-cell cooperation without reprograming tolerogenic pDC
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-17-2549
– volume: 9
  start-page: 114
  year: 2009
  ident: CR57
  article-title: Activation of P2X(7)-mediated apoptosis inhibits DMBA/TPA-induced formation of skin papillomas and cancer in mice
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-9-114
– volume: 24
  start-page: 5407
  year: 2018
  end-page: 5421
  ident: CR110
  article-title: Cancer-stimulated CAFs enhance monocyte differentiation and protumoral TAM activation via IL6 and GM-CSF secretion
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-18-0125
– volume: 24
  start-page: 84
  year: 2018
  end-page: 92
  ident: CR37
  article-title: Mechanosensitive ion channels: TRPV4 and P2X7 in disseminating cancer cells
  publication-title: Cancer J
  doi: 10.1097/PPO.0000000000000312
– volume: 9
  start-page: 449
  issue: 1
  year: 2015
  end-page: 453
  ident: CR53
  article-title: P2X7 mRNA expression in non-small cell lung cancer: MicroRNA regulation and prognostic value
  publication-title: Oncol Lett
  doi: 10.3892/ol.2014.2620
– volume: 14
  start-page: 1014
  year: 2013
  end-page: 1022
  ident: CR73
  article-title: Innate and adaptive immune cells in the tumor microenvironment
  publication-title: Nat Immunol
  doi: 10.1038/ni.2703
– volume: 19
  start-page: 200
  year: 2020
  end-page: 218
  ident: CR95
  article-title: NK cells for cancer immunotherapy
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/s41573-019-0052-1
– volume: 17
  start-page: 355
  year: 2019
  ident: CR108
  article-title: Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients
  publication-title: J Transl Med
  doi: 10.1186/s12967-019-2101-2
– volume: 35
  start-page: 175
  year: 2018
  ident: CR77
  article-title: Effect of tumor relevant acidic environment in the interaction of a N-hydroxyindole-2-carboxylic derivative with the phospholipid bilayer
  publication-title: Pharm Res
  doi: 10.1007/s11095-018-2449-7
– volume: 8
  start-page: 48972
  year: 2017
  end-page: 48982
  ident: CR36
  article-title: P2X7 receptor and NLRP3 Inflammasome activation in head and neck cancer
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.16903
– volume: 8
  start-page: e80707
  year: 2013
  ident: CR54
  article-title: miR-150 promotes human breast cancer growth and malignant behavior by targeting the pro-apoptotic purinergic P2X7 receptor
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0080707
– volume: 237
  start-page: 116952
  year: 2019
  ident: CR62
  article-title: Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2019.116952
– volume: 75
  start-page: 835
  year: 2015
  end-page: 845
  ident: CR162
  article-title: Genetic and pharmacological inactivation of the purinergic P2RX7 receptor dampens inflammation but increases tumor incidence in a mouse model of colitis-associated cancer
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-14-1778
– volume: 56
  start-page: 15
  year: 2019
  ident: CR50
  article-title: Tumor Microenvironment
  publication-title: Medicina (Kaunas)
  doi: 10.3390/medicina56010015
– volume: 120
  start-page: 16
  year: 2019
  end-page: 25
  ident: CR96
  article-title: Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
  publication-title: Br J Cancer
  doi: 10.1038/s41416-018-0333-1
– volume: 110
  start-page: 11091
  year: 2013
  end-page: 11096
  ident: CR174
  article-title: CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1222251110
– volume: 8
  start-page: 67254
  year: 2017
  end-page: 67268
  ident: CR139
  article-title: Hyperthermia and associated changes in membrane fluidity potentiate P2X7 activation to promote tumor cell death
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.18595
– volume: 115
  start-page: 1955
  year: 2014
  end-page: 1966
  ident: CR167
  article-title: Paracrine stimulation of P2X7 receptor by ATP activates a proliferative pathway in ovarian carcinoma cells
  publication-title: J Cell Biochem
– volume: 356
  start-page: 156
  year: 2015
  end-page: 164
  ident: CR67
  article-title: The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2014.04.001
– volume: 16
  start-page: 257
  year: 2017
  end-page: 265
  ident: CR29
  article-title: Purinergic signalling and neurological diseases: an update
  publication-title: CNS Neurol Disord Drug Targets
  doi: 10.2174/1871527315666160922104848
– volume: 8
  year: 2013
  ident: 9761_CR138
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0060184
– volume: 15
  start-page: 367
  year: 2019
  ident: 9761_CR129
  publication-title: Purinergic Signal
  doi: 10.1007/s11302-019-09675-0
– volume: 45
  start-page: 1653
  year: 2018
  ident: 9761_CR65
  publication-title: Mol Biol Rep
  doi: 10.1007/s11033-018-4309-2
– volume: 158
  start-page: 104875
  year: 2020
  ident: 9761_CR21
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2020.104875
– volume: 351
  start-page: 242
  year: 2014
  ident: 9761_CR122
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2014.06.008
– volume: 33
  start-page: 83
  year: 2017
  ident: 9761_CR48
  publication-title: Cytokine Growth Factor Rev
  doi: 10.1016/j.cytogfr.2016.11.004
– volume: 19
  start-page: 216
  year: 2019
  ident: 9761_CR98
  publication-title: BMC Complement Altern Med
  doi: 10.1186/s12906-019-2615-4
– volume: 8
  start-page: e80707
  year: 2013
  ident: 9761_CR54
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0080707
– volume: 260
  start-page: 79
  year: 2008
  ident: 9761_CR100
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2007.10.025
– volume: 75
  start-page: 835
  year: 2015
  ident: 9761_CR162
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-14-1778
– volume: 38
  start-page: 3636
  year: 2019
  ident: 9761_CR160
  publication-title: Oncogene.
  doi: 10.1038/s41388-019-0684-y
– volume: 125
  start-page: 109844
  year: 2020
  ident: 9761_CR5
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2020.109844
– volume: 9
  start-page: 30543
  year: 2017
  ident: 9761_CR75
  publication-title: ACS Appl Mater Interfaces
  doi: 10.1021/acsami.7b10840
– volume: 2016
  start-page: 6058147
  year: 2016
  ident: 9761_CR49
  publication-title: Mediat Inflamm
  doi: 10.1155/2016/6058147
– volume: 155
  start-page: 19
  year: 2020
  ident: 9761_CR11
  publication-title: Brain Res Bull
  doi: 10.1016/j.brainresbull.2019.11.006
– volume: 6
  start-page: 1053
  year: 2016
  ident: 9761_CR124
  publication-title: Theranostics.
  doi: 10.7150/thno.14843
– volume: 47
  start-page: 110
  year: 2019
  ident: 9761_CR41
  publication-title: Curr Opin Pharmacol
  doi: 10.1016/j.coph.2019.03.001
– volume: 234
  start-page: 19352
  year: 2019
  ident: 9761_CR94
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.28657
– volume: 45
  start-page: 932
  year: 2013
  ident: 9761_CR155
  publication-title: Int J Biochem Cell Biol
  doi: 10.1016/j.biocel.2013.02.009
– volume: 22
  start-page: 819
  year: 2015
  ident: 9761_CR33
  publication-title: Curr Med Chem
  doi: 10.2174/0929867321666140706130415
– volume: 12
  start-page: 59
  year: 2016
  ident: 9761_CR15
  publication-title: Purinergic Signal
  doi: 10.1007/s11302-015-9493-0
– volume: 172
  start-page: 841
  year: 2018
  ident: 9761_CR113
  publication-title: Cell
  doi: 10.1016/j.cell.2018.01.009
– volume: 71
  start-page: 1184
  year: 2019
  ident: 9761_CR119
  publication-title: Pharmacol Rep
  doi: 10.1016/j.pharep.2019.08.002
– volume: 19
  start-page: 200
  year: 2020
  ident: 9761_CR95
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/s41573-019-0052-1
– volume: 44
  start-page: 206
  year: 2004
  ident: 9761_CR173
  publication-title: Histopathology.
  doi: 10.1111/j.0309-0167.2004.01798.x
– volume: 452
  start-page: 513
  year: 2006
  ident: 9761_CR35
  publication-title: Pflugers Arch
  doi: 10.1007/s00424-006-0070-9
– volume: 595
  start-page: 2439
  year: 2017
  ident: 9761_CR59
  publication-title: J Physiol
  doi: 10.1113/JP273309
– volume: 35
  start-page: 175
  year: 2018
  ident: 9761_CR77
  publication-title: Pharm Res
  doi: 10.1007/s11095-018-2449-7
– volume: 13
  start-page: 206
  year: 2011
  ident: 9761_CR13
  publication-title: Neoplasia.
  doi: 10.1593/neo.101332
– volume: 70
  start-page: 811
  year: 2013
  ident: 9761_CR154
  publication-title: Eur J Med Chem
  doi: 10.1016/j.ejmech.2013.10.026
– volume: 17
  start-page: 355
  year: 2019
  ident: 9761_CR108
  publication-title: J Transl Med
  doi: 10.1186/s12967-019-2101-2
– volume: 223
  start-page: 30
  year: 2017
  ident: 9761_CR116
  publication-title: Biophys Chem
  doi: 10.1016/j.bpc.2017.02.005
– volume: 356
  start-page: 156
  year: 2015
  ident: 9761_CR67
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2014.04.001
– volume: 6
  start-page: 28743
  year: 2015
  ident: 9761_CR140
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.4926
– volume: 45
  start-page: 2625
  year: 2018
  ident: 9761_CR144
  publication-title: Mol Biol Rep
  doi: 10.1007/s11033-018-4432-0
– volume: 14
  start-page: 1014
  year: 2013
  ident: 9761_CR73
  publication-title: Nat Immunol
  doi: 10.1038/ni.2703
– volume: 8
  start-page: 67254
  year: 2017
  ident: 9761_CR139
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.18595
– volume: 14
  start-page: 1
  year: 2018
  ident: 9761_CR10
  publication-title: Purinergic Signal
  doi: 10.1007/s11302-017-9593-0
– volume: 558
  start-page: 600
  year: 2018
  ident: 9761_CR46
  publication-title: Nature.
  doi: 10.1038/s41586-018-0235-7
– volume: 24
  start-page: 5407
  year: 2018
  ident: 9761_CR110
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-18-0125
– volume: 13
  start-page: 16
  year: 2014
  ident: 9761_CR17
  publication-title: J Negat Results Biomed
  doi: 10.1186/1477-5751-13-16
– volume: 64
  start-page: 61
  year: 2017
  ident: 9761_CR136
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2017.03.019
– volume: 78
  start-page: 3280
  year: 2018
  ident: 9761_CR72
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-17-2549
– volume: 30
  start-page: 2108
  issue: 18
  year: 2011
  ident: 9761_CR56
  publication-title: Oncogene.
  doi: 10.1038/onc.2010.593
– volume: 22
  start-page: 878
  year: 2015
  ident: 9761_CR40
  publication-title: Curr Med Chem
  doi: 10.2174/0929867321666141012172913
– volume: 8
  start-page: 3723
  year: 2009
  ident: 9761_CR123
  publication-title: Cell Cycle
  doi: 10.4161/cc.8.22.10026
– volume: 20
  start-page: 357
  year: 2017
  ident: 9761_CR104
  publication-title: Cancer Biomark
  doi: 10.3233/CBM-170258
– volume: 100
  start-page: 5205
  year: 2003
  ident: 9761_CR68
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0935978100
– volume: 147
  start-page: 467
  year: 2016
  ident: 9761_CR151
  publication-title: J Gen Physiol
  doi: 10.1085/jgp.201611595
– volume: 288
  start-page: G1024
  year: 2005
  ident: 9761_CR147
  publication-title: Am J Physiol Gastrointest Liver Physiol
  doi: 10.1152/ajpgi.00211.2004
– volume: 91
  start-page: 847
  year: 2012
  ident: 9761_CR69
  publication-title: Eur J Cell Biol
  doi: 10.1016/j.ejcb.2012.04.004
– volume: 60
  start-page: 74
  year: 2017
  ident: 9761_CR90
  publication-title: Leuk Res
  doi: 10.1016/j.leukres.2017.07.004
– volume: 1060
  start-page: 99
  year: 2018
  ident: 9761_CR45
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-3-319-78127-3_6
– volume: 10
  start-page: 801
  year: 2019
  ident: 9761_CR121
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-019-2042-y
– volume: 2015
  start-page: 2584
  year: 1848
  ident: 9761_CR127
  publication-title: Biochim Biophys Acta
– volume: 93
  start-page: 3684
  year: 1996
  ident: 9761_CR30
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.93.8.3684
– volume: 288
  start-page: 198
  year: 2019
  ident: 9761_CR61
  publication-title: Immunol Rev
  doi: 10.1111/imr.12738
– volume: 399
  start-page: 661
  year: 2018
  ident: 9761_CR66
  publication-title: Biol Chem
  doi: 10.1515/hsz-2018-0121
– volume: 26
  start-page: 94
  year: 2017
  ident: 9761_CR84
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2017.06.016
– volume: 22
  start-page: 866
  year: 2015
  ident: 9761_CR28
  publication-title: Curr Med Chem
  doi: 10.2174/0929867322666141210155311
– volume: 101
  start-page: 106
  year: 2008
  ident: 9761_CR148
  publication-title: BJU Int
  doi: 10.1111/j.1464-410X.2007.07293.x
– volume: 47
  start-page: 643
  year: 2018
  ident: 9761_CR131
  publication-title: Pancreas.
  doi: 10.1097/MPA.0000000000001055
– volume: 629
  start-page: 81
  year: 2019
  ident: 9761_CR4
  publication-title: Methods Enzymol
  doi: 10.1016/bs.mie.2019.10.006
– volume: 37
  start-page: 3553
  year: 2017
  ident: 9761_CR117
  publication-title: Anticancer Res
  doi: 10.21873/anticanres.11345
– volume: 24
  start-page: E3575
  year: 2019
  ident: 9761_CR118
  publication-title: Molecules.
  doi: 10.3390/molecules24193575
– volume: 38
  start-page: 103
  year: 2019
  ident: 9761_CR2
  publication-title: Cancer Metastasis Rev
  doi: 10.1007/s10555-019-09796-3
– volume: 360
  start-page: 1935
  year: 2002
  ident: 9761_CR19
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(02)11917-9
– volume: 70
  start-page: 855
  year: 2010
  ident: 9761_CR7
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-09-3566
– volume: 41
  start-page: 362
  year: 2009
  ident: 9761_CR168
  publication-title: Acta Biochim Biophys Sin Shanghai
  doi: 10.1093/abbs/gmp016
– volume: 17
  start-page: 537
  year: 2016
  ident: 9761_CR107
  publication-title: J Zhejiang Univ Sci B
  doi: 10.1631/jzus.B1500266
– volume: 9
  start-page: 449
  issue: 1
  year: 2015
  ident: 9761_CR53
  publication-title: Oncol Lett
  doi: 10.3892/ol.2014.2620
– volume: 36
  start-page: 455
  year: 2016
  ident: 9761_CR76
  publication-title: Oncol Rep
  doi: 10.3892/or.2016.4827
– ident: 9761_CR169
  doi: 10.1038/srep32602
– volume: 89
  start-page: 199
  year: 2018
  ident: 9761_CR101
  publication-title: J Neurosci Res
  doi: 10.1002/jnr.22538
– volume: 92
  start-page: 502
  year: 2016
  ident: 9761_CR78
  publication-title: Int J Radiat Biol
  doi: 10.1080/09553002.2016.1206222
– volume: 13
  start-page: 1313
  year: 2009
  ident: 9761_CR128
  publication-title: Expert Opin Ther Targets
  doi: 10.1517/14728220903277249
– volume: 10
  start-page: 166
  year: 2016
  ident: 9761_CR146
  publication-title: Mol Oncol
  doi: 10.1016/j.molonc.2015.09.006
– volume: 72
  start-page: 2957
  year: 2012
  ident: 9761_CR161
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-11-1947
– volume: 64
  start-page: 388
  year: 2019
  ident: 9761_CR130
  publication-title: Adv Med Sci
  doi: 10.1016/j.advms.2019.05.002
– volume: 38
  start-page: 276
  year: 2010
  ident: 9761_CR171
  publication-title: Endocrine.
  doi: 10.1007/s12020-010-9384-7
– volume: 24
  start-page: 84
  year: 2018
  ident: 9761_CR37
  publication-title: Cancer J
  doi: 10.1097/PPO.0000000000000312
– volume: 145
  start-page: 1068
  year: 2019
  ident: 9761_CR134
  publication-title: Int J Cancer
  doi: 10.1002/ijc.32207
– volume: 234
  start-page: 5683
  year: 2019
  ident: 9761_CR112
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.27411
– volume: 115
  start-page: 1955
  year: 2014
  ident: 9761_CR167
  publication-title: J Cell Biochem
– volume: 14
  start-page: 399
  year: 2017
  ident: 9761_CR92
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/nrclinonc.2016.217
– volume: 2018
  start-page: 286
  year: 1869
  ident: 9761_CR38
  publication-title: Biochim Biophys Acta Rev Cancer
– volume: 27
  start-page: 109
  year: 2017
  ident: 9761_CR89
  publication-title: Cell Res
  doi: 10.1038/cr.2016.151
– volume: 74
  start-page: 103
  year: 2016
  ident: 9761_CR103
  publication-title: Adv Clin Chem
  doi: 10.1016/bs.acc.2015.12.005
– volume: 152
  start-page: 67
  year: 2004
  ident: 9761_CR142
  publication-title: J Neuroimmunol
  doi: 10.1016/j.jneuroim.2004.04.005
– volume: 53
  start-page: 469
  year: 2018
  ident: 9761_CR64
  publication-title: Int J Oncol
– volume: 12
  start-page: 860
  year: 2012
  ident: 9761_CR120
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3380
– volume: 126
  start-page: 97
  year: 2017
  ident: 9761_CR3
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2017.05.004
– volume: 16
  start-page: 257
  year: 2017
  ident: 9761_CR29
  publication-title: CNS Neurol Disord Drug Targets
  doi: 10.2174/1871527315666160922104848
– volume: 5
  start-page: 3364
  year: 2014
  ident: 9761_CR125
  publication-title: Nat Commun
  doi: 10.1038/ncomms4364
– volume: 163
  start-page: 2002
  year: 2000
  ident: 9761_CR34
  publication-title: J Urol
  doi: 10.1016/S0022-5347(05)67618-5
– volume: 16
  start-page: 282
  year: 2019
  ident: 9761_CR111
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/s41575-019-0115-0
– volume: 78
  start-page: 1115
  year: 2009
  ident: 9761_CR152
  publication-title: Biochem Pharmacol
  doi: 10.1016/j.bcp.2009.06.016
– volume: 9
  start-page: 1722
  year: 2018
  ident: 9761_CR43
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.01722
– volume: 16
  start-page: 582
  year: 2016
  ident: 9761_CR109
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc.2016.73
– volume: 95
  start-page: 83
  year: 2015
  ident: 9761_CR157
  publication-title: Neuropharmacology.
  doi: 10.1016/j.neuropharm.2015.02.014
– volume: 5
  start-page: 16222
  year: 2015
  ident: 9761_CR137
  publication-title: Sci Rep
  doi: 10.1038/srep16222
– volume: 38
  start-page: 389
  year: 2011
  ident: 9761_CR18
  publication-title: Int J Immunogenet
  doi: 10.1111/j.1744-313X.2011.01019.x
– volume: 773
  start-page: 27
  year: 2014
  ident: 9761_CR47
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-1-4899-8032-8_2
– volume: 126
  start-page: 1208
  year: 2016
  ident: 9761_CR102
  publication-title: J Clin Invest
  doi: 10.1172/JCI81135
– volume: 132
  start-page: 563
  year: 2008
  ident: 9761_CR26
  publication-title: J Gen Physiol
  doi: 10.1085/jgp.200810059
– volume: 4
  start-page: 130000
  year: 2019
  ident: 9761_CR79
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.130000
– volume: 90
  start-page: 516
  year: 2015
  ident: 9761_CR143
  publication-title: Lung Cancer
  doi: 10.1016/j.lungcan.2015.10.005
– volume: 22
  start-page: 101
  year: 2014
  ident: 9761_CR150
  publication-title: Curr Opin Otolaryngol Head Neck Surg
  doi: 10.1097/MOO.0000000000000031
– volume: 14
  start-page: 201
  year: 2015
  ident: 9761_CR170
  publication-title: Mol Cancer
  doi: 10.1186/s12943-015-0469-z
– volume: 59
  start-page: 7410
  year: 2016
  ident: 9761_CR166
  publication-title: J Med Chem
  doi: 10.1021/acs.jmedchem.5b01690
– volume: 8
  start-page: 48972
  year: 2017
  ident: 9761_CR36
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.16903
– volume: 26
  start-page: 148091
  year: 2019
  ident: 9761_CR115
  publication-title: Biochim Biophys Acta Bioenerg
– volume: 485
  start-page: 207
  year: 2012
  ident: 9761_CR24
  publication-title: Nature.
  doi: 10.1038/nature11010
– volume: 104
  start-page: 102310
  year: 2019
  ident: 9761_CR81
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2019.102310
– volume: 20
  start-page: E4413
  year: 2019
  ident: 9761_CR80
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms20184413
– volume: 22
  start-page: 587
  year: 2018
  ident: 9761_CR91
  publication-title: Cancer Biomark
  doi: 10.3233/CBM-181368
– volume: 977
  start-page: 119
  year: 2017
  ident: 9761_CR71
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-3-319-55231-6_16
– volume: 316
  start-page: L58
  year: 2019
  ident: 9761_CR27
  publication-title: Am J Phys Lung Cell Mol Phys
– volume: 10
  start-page: 612
  year: 2019
  ident: 9761_CR39
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2019.00612
– volume: 237
  start-page: 116952
  year: 2019
  ident: 9761_CR62
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2019.116952
– volume: 8
  start-page: 291
  year: 2017
  ident: 9761_CR42
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2017.00291
– volume: 5
  year: 2014
  ident: 9761_CR97
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2014.109
– volume: 34
  start-page: 103
  year: 2015
  ident: 9761_CR135
  publication-title: Oncol Rep
  doi: 10.3892/or.2015.3979
– volume: 6
  start-page: e19983
  year: 2011
  ident: 9761_CR156
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0019983
– volume: 35
  start-page: 1547
  year: 2014
  ident: 9761_CR164
  publication-title: Carcinogenesis.
  doi: 10.1093/carcin/bgu019
– volume: 1051
  start-page: 55
  year: 2017
  ident: 9761_CR16
  publication-title: Adv Exp Med Biol
  doi: 10.1007/5584_2017_55
– volume: 34
  start-page: 5240
  year: 2015
  ident: 9761_CR141
  publication-title: Oncogene.
  doi: 10.1038/onc.2014.444
– volume: 2019
  start-page: 455
  year: 1871
  ident: 9761_CR106
  publication-title: Biochim Biophys Acta Rev Cancer
– volume: 371
  start-page: 20150427
  year: 2016
  ident: 9761_CR14
  publication-title: Philos Trans R Soc Lond Ser B Biol Sci
  doi: 10.1098/rstb.2015.0427
– volume: 18
  start-page: 601
  year: 2018
  ident: 9761_CR8
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-018-0037-0
– volume: 22
  start-page: 902
  year: 2015
  ident: 9761_CR22
  publication-title: Curr Med Chem
  doi: 10.2174/0929867321666141215094749
– volume: 446
  start-page: 1002
  year: 2014
  ident: 9761_CR12
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2014.03.048
– volume: 120
  start-page: 16
  year: 2019
  ident: 9761_CR96
  publication-title: Br J Cancer
  doi: 10.1038/s41416-018-0333-1
– volume: 276
  start-page: 5307
  year: 2009
  ident: 9761_CR145
  publication-title: FEBS J
  doi: 10.1111/j.1742-4658.2009.07228.x
– volume: 17
  start-page: 1617
  year: 2017
  ident: 9761_CR74
  publication-title: Anti Cancer Agents Med Chem
– volume: 110
  start-page: 11091
  year: 2013
  ident: 9761_CR174
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1222251110
– volume: 7
  start-page: e38358
  year: 2018
  ident: 9761_CR87
  publication-title: Elife.
  doi: 10.7554/eLife.38358
– volume: 7
  start-page: 284
  year: 2019
  ident: 9761_CR83
  publication-title: J Immunother Cancer
  doi: 10.1186/s40425-019-0773-z
– volume: 71
  start-page: 3059
  year: 2014
  ident: 9761_CR86
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-014-1600-9
– volume: 36
  start-page: 582
  year: 2019
  ident: 9761_CR6
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2019.10.007
– volume: 56
  start-page: 15
  year: 2019
  ident: 9761_CR50
  publication-title: Medicina (Kaunas)
  doi: 10.3390/medicina56010015
– volume: 1866
  start-page: 118523
  year: 2019
  ident: 9761_CR70
  publication-title: Biochim Biophys Acta, Mol Cell Res
  doi: 10.1016/j.bbamcr.2019.118523
– volume: 75
  start-page: 689
  year: 2018
  ident: 9761_CR85
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-017-2686-7
– volume: 260
  start-page: 43
  year: 2019
  ident: 9761_CR149
  publication-title: Handb Exp Pharmacol
  doi: 10.1007/164_2019_312
– volume: 22
  start-page: 915
  year: 2015
  ident: 9761_CR158
  publication-title: Curr Med Chem
  doi: 10.2174/0929867321666141215093513
– volume: 10
  start-page: 487
  year: 2014
  ident: 9761_CR165
  publication-title: Purinergic Signal
  doi: 10.1007/s11302-014-9411-x
– volume: 89
  start-page: 3235
  year: 2003
  ident: 9761_CR153
  publication-title: J Neurophysiol
  doi: 10.1152/jn.01171.2002
– ident: 9761_CR132
  doi: 10.1371/journal.pone.0114371
– volume: 452
  start-page: 197
  year: 2014
  ident: 9761_CR55
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2014.07.101
– volume: 242
  start-page: 334
  year: 2017
  ident: 9761_CR60
  publication-title: J Pathol
  doi: 10.1002/path.4907
– volume: 2010
  start-page: 1173
  year: 1800
  ident: 9761_CR9
  publication-title: Biochim Biophys Acta
– volume: 22
  start-page: 851
  year: 2015
  ident: 9761_CR20
  publication-title: Curr Med Chem
  doi: 10.2174/0929867321666141215094050
– volume: 50
  start-page: 302
  year: 2019
  ident: 9761_CR88
  publication-title: Immunity.
  doi: 10.1016/j.immuni.2019.01.020
– volume: 37
  start-page: 208
  year: 2016
  ident: 9761_CR44
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2016.01.004
– volume: 60
  start-page: 1114
  year: 2017
  ident: 9761_CR58
  publication-title: Sci China Life Sci
  doi: 10.1007/s11427-017-9178-y
– volume: 12
  start-page: E2342
  year: 2020
  ident: 9761_CR163
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers12092342
– volume: 81
  start-page: 43
  year: 2019
  ident: 9761_CR23
  publication-title: Annu Rev Physiol
  doi: 10.1146/annurev-physiol-020518-114259
– volume: 1699
  start-page: 23
  year: 2018
  ident: 9761_CR52
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-4939-7435-1_2
– volume: 291
  start-page: 93
  year: 2015
  ident: 9761_CR172
  publication-title: Neuroscience.
  doi: 10.1016/j.neuroscience.2015.02.011
– volume: 41
  start-page: 351
  year: 2010
  ident: 9761_CR133
  publication-title: Mol Neurobiol
  doi: 10.1007/s12035-010-8120-x
– volume: 40
  start-page: 72
  year: 2015
  ident: 9761_CR105
  publication-title: Semin Cell Dev Biol
  doi: 10.1016/j.semcdb.2015.02.009
– volume: 9
  start-page: 114
  year: 2009
  ident: 9761_CR57
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-9-114
– volume: 80
  start-page: 23
  year: 2018
  ident: 9761_CR63
  publication-title: Oral Oncol
  doi: 10.1016/j.oraloncology.2018.03.004
– volume: 17
  start-page: 1829
  year: 2016
  ident: 9761_CR114
  publication-title: Curr Drug Targets
  doi: 10.2174/1389450117666160711154529
– volume: 54
  start-page: 738
  year: 2006
  ident: 9761_CR25
  publication-title: Glia.
  doi: 10.1002/glia.20397
– volume: 4
  start-page: 3832
  year: 2016
  ident: 9761_CR126
  publication-title: J Mater Chem B
  doi: 10.1039/C5TB02764K
– volume: 6
  start-page: 26280
  year: 2016
  ident: 9761_CR159
  publication-title: Sci Rep
  doi: 10.1038/srep26280
– volume: S0141-8130
  start-page: 36746
  year: 2019
  ident: 9761_CR93
  publication-title: Int J Biol Macromol
– volume: 569
  start-page: 270
  year: 2019
  ident: 9761_CR82
  publication-title: Nature.
  doi: 10.1038/s41586-019-1170-y
– volume: 22
  start-page: 845
  year: 2015
  ident: 9761_CR32
  publication-title: Curr Med Chem
  doi: 10.2174/0929867321666141011195351
– volume: 14
  start-page: 135
  year: 2017
  ident: 9761_CR31
  publication-title: J Neuroinflammation
  doi: 10.1186/s12974-017-0904-8
– volume: 79
  start-page: 4557
  year: 2019
  ident: 9761_CR51
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-18-3962
– volume: 75
  start-page: 635
  year: 2015
  ident: 9761_CR99
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-14-1259
– volume: 12
  start-page: 84
  year: 2019
  ident: 9761_CR1
  publication-title: J Hematol Oncol
  doi: 10.1186/s13045-019-0772-z
SSID ssj0054239
Score 2.359205
SecondaryResourceType review_article
Snippet The development of tumors is a complex pathological process involving multiple factors, multiple steps, and multiple genes. Their prevention and treatment have...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 151
SubjectTerms Apoptosis
Biomedical and Life Sciences
Biomedicine
Cancer Research
Cancer therapies
Cell proliferation
Fluidity
Human Physiology
Membrane fluidity
Neurosciences
Pharmacology/Toxicology
Purine P2X receptors
Purine receptors
Review
Review Article
Tumor cells
Tumor microenvironment
Tumors
Title Effect of P2X purinergic receptors in tumor progression and as a potential target for anti-tumor therapy
URI https://link.springer.com/article/10.1007/s11302-020-09761-8
https://www.ncbi.nlm.nih.gov/pubmed/33420658
https://www.proquest.com/docview/2525685673
https://www.proquest.com/docview/2476561674
https://pubmed.ncbi.nlm.nih.gov/PMC7954979
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB5Be-GCgPJIKZWREBew1PUjdo5b1KUCqeLASsspchJbXYkmq2720H_PjJ3saikgcYoU23GS8eOz55vPAO8mSjif-wl2JFFxVajArROaF8HmwZ8JHxLL9yq_nKsvC70YgsLWI9t9dEnGkXoX7EY-Nk7LnTOcQyfcPoRDTWt3bMVzMR3HX02SdlEl1UhyTtohVObPz9ifju5hzPtUyd_8pXEamj2BxwN-ZNNk8KfwwLfP4Gja4tr55o69Z5HRGbfKj-A6SROzLrBvYsFWmxTpt6wZDnN-RefssGXL-s1Nd8siUSuJdDDXNsytmWOrric2EVaYGOMMIS6m9kueCqXorbvnMJ9dfP90yYeTFXitjOq503UlKi-8lb4yupChya0LJtC5Y6pASFNVeF_aRjhlmlAHJ5QuvEd4IURj5Qs4aLvWvwImG1tTNK4tCHrVzjW5EcrT7kiNxW0Gk_EHl_UgO06nX_wsd4LJZJQSjVJGo5RY5sO2zCqJbvwz98lot3LogOtSaMRyVudGZvB2m4xdh_whrvXdBvMog2iWwjAyeJnMvK1OSiUInWVg9hrANgPJcu-ntMvrKM9tyHNqigw-jk1l91p__4rj_8v-Gh4JYtdENtwJHPS3G_8G4VFfncLhdHZ-fkXXzz--XpzG3vELFpQJrg
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9QwEB2VcoBLBRRooICRql7AUtd2Yue4QlQLLVUPXWlvkZPY6kptsupmD_33zNjJrrYFJK6xJ1_jj2fPm2eAo5ES1mVuhB1JlFzlynNjRcpzbzLvToTzkeV7kU2m6ucsnfVJYcuB7T6EJMNIvUl2oxgbp-XOCc6hI26ewFMEA4aIXFMxHsbflCTtgkqqlhScNH2qzJ_vsT0dPcKYj6mSD-KlYRo6fQF7PX5k4-jwl7DjmlewP25w7Xx7z45ZYHSGrfJ9uI7SxKz17FLM2GIVM_3mFcNhzi3onB02b1i3um3vWCBqRZEOZpua2SWzbNF2xCbCB0bGOEOIi6XdnEejmL11_xqmp9-vvk14f7ICr5RWHbdpVYrSCWekK3WaS19nxnrt6dwxlSOkKUu8Lk0trNK1r7wVKs2dQ3ghRG3kG9ht2sYdAJO1qSgb1-QEvSpr60wL5Wh3pEJzk8Bo-MFF1cuO0-kXN8VGMJmcUqBTiuCUAm2-rG0WUXTjn7UPB78VfQdcFiJFLGfSTMsEPq-LsetQPMQ2rl1hHaURzVIaRgJvo5vXj5NSCUJnCeitBrCuQLLc2yXN_DrIc2uKnOo8ga9DU9m81t-_4t3_Vf8EzyZXv86L8x8XZ-_huSCmTWDGHcJud7dyHxAqdeXH0DN-AyBbCZE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB5BkRAXBJRHoICREBeI2thO7BxXwKo8VPXASnuLnMRWV2qdqM0e-u-ZsZNdlgIS13gmr_Hjs2fmG4C3meTGFjbDgcTrVJbSpdrwPC2dLpw94tbFKN-T4nghvy7z5S9Z_CHafXJJxpwGYmnyw2HfusNt4hv521La-hzhepql-jbcwek4o3694LNpLs6J3i4wpipBjko9ps38-R67S9MNvHkzbPI332lYkuYP4P6IJdksGv8h3LL-EezPPO6jL67ZOxaiO8Ox-T6cRZpi1jl2ypesX8esv1XDcMqzPdXcYSvPhvVFd8lC0FYk7GDGt8xcMcP6jn4QdlcWo8cZwl1sHVZpVIqZXNePYTH__OPjcTpWWUgbqeSQmrypeW251cLWKi-FawttnHJUg0yWCG_qGq8L3XIjVesaZ7jMS2sRanDeavEE9nzn7TNgotUNZebqkmBYY0xbKC4tnZQ0qK4TyKYfXDUjBTlVwjivtuTJZJQKjVIFo1So836j00cCjn9KH0x2q8bBeFXxHHGdzgslEnizacZhRL4R4223RhmpENlSSkYCT6OZN48TQnJCagmonQ6wESCK7t0WvzoLVN2KvKiqTODD1FW2r_X3r3j-f-Kv4e7pp3n1_cvJtxdwj1PQTQiSO4C94XJtXyJqGupXYWD8BDEqDc0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+P2X+purinergic+receptors+in+tumor+progression+and+as+a+potential+target+for+anti-tumor+therapy&rft.jtitle=Purinergic+signalling&rft.au=Zhang%2C+Wen-jun&rft.date=2021-03-01&rft.pub=Springer+Netherlands&rft.issn=1573-9538&rft.eissn=1573-9546&rft.volume=17&rft.issue=1&rft.spage=151&rft.epage=162&rft_id=info:doi/10.1007%2Fs11302-020-09761-8&rft_id=info%3Apmid%2F33420658&rft.externalDocID=PMC7954979
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1573-9538&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1573-9538&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1573-9538&client=summon